Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

452 records found for:
Title = Cardiovascular Disease
Year =

  1. Silverberg MJ, Levine TM, Lea AN, Williams AE, Alexeeff SE, Bryant K, Cavassini M, Flamm JA, Hare CB, Ingle SM, Justice AC, Lam JO, Sterling SA, Horberg MA, Satre DD. Cardiovascular Disease Risk Factor Control in People With and Without Human Immunodeficiency Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Jan 16.
  2. Adeola J, Obiezu F, Odukoya O, Igwilo U, Usinoma A, Bahiru E, May FP. Barriers and Facilitators to Risk Reduction of Cardiovascular Disease in Hypertensive Patients in Nigeria. Annals of global health. 2023 Dec 13; 89(1):88.
  3. Agarwal MA, Ziaeian B. Cardiovascular Disease's Lonely Hearts Club. The American journal of cardiology. 2023 Nov 10.
  4. Musoke L, Bosworth HB, Dickson C, Gentry P, Strawbridge E, Subramaniam S, Gierisch J, Smith V, Woolson S, Pura J, Amutuhaire W, Naggie S, Schexnayder J, Hall K, Longenecker CT, Harris NM, Rogers C, Van Epps P, for V-EXTRA-CVD Group. A telehealth-delivered intervention to extend the veteran HIV treatment cascade for cardiovascular disease prevention: V-EXTRA-CVD study protocol for a randomized controlled trial. HIV research & clinical practice. 2023 Dec 1; 24(1):2261747.
  5. Ebrahimi R, Yano EM, Alvarez CA, Dennis PA, Shroyer AL, Beckham JC, Sumner JA. Trends in Cardiovascular Disease Mortality in US Women Veterans vs Civilians. JAMA Network Open. 2023 Oct 2; 6(10):e2340242.
  6. Ahmed ST, Li R, Richardson P, Ghosh S, Steele L, White DL, Djotsa AN, Sims K, Gifford E, Hauser ER, Virani SS, Morgan R, Delclos G, Helmer DA. Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War Veterans. Journal of the American Heart Association. 2023 Oct 3; 12(19):e029575.
  7. Xu Y, Derakhshan A, Hysaj O, Wildisen L, Ittermann T, Pingitore A, Abolhassani N, Medici M, Kiemeney LALM, Riksen NP, Dullaart RPF, Trompet S, Dörr M, Brown SJ, Schmidt B, Führer-Sakel D, Vanderpump MPJ, Muendlein A, Drexel H, Fink HA, Ikram MK, Kavousi M, Rhee CM, Bensenor IM, Azizi F, Hankey GJ, Iacoviello M, Imaizumi M, Ceresini G, Ferrucci L, Sgarbi JA, Bauer DC, Wareham N, Boelaert K, Bakker SJL, Jukema JW, Vaes B, Iervasi G, Yeap BB, Westendorp RGJ, Korevaar TIM, Völzke H, Razvi S, Gussekloo J, Walsh JP, Cappola AR, Rodondi N, Peeters RP, Chaker L, Thyroid Studies Collaboration. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis. The lancet. Diabetes & endocrinology. 2023 Oct 1; 11(10):743-754.
  8. Eberly LA, Shultz K, Merino M, Brueckner MY, Benally E, Tennison A, Biggs S, Hardie L, Tian Y, Nathan AS, Khatana SAM, Shea JA, Lewis E, Bukhman G, Shin S, Groeneveld PW. Cardiovascular Disease Burden and Outcomes Among American Indian and Alaska Native Medicare Beneficiaries. JAMA Network Open. 2023 Sep 5; 6(9):e2334923.
  9. Hegde SM, Claggett BL, Udell JA, Kim K, Joseph J, Farkouh ME, Peikert A, Bhatt AS, Tattersall MC, Bhatt DL, Cooper LS, Solomon SD, Vardeny O. Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2023 Sep 5; 6(9):e2331284.
  10. Levine DA, Whitney RT, Galecki AT, Fagerlin A, Wallner LP, Shore S, Langa KM, Nallamothu BK, Morgenstern LB, Giordani B, Reale BK, Blair EM, Sharma A, Kabeto MU, Plassman BL, Zahuranec DB. Patient Cognitive Status and Physician Recommendations for Cardiovascular Disease Treatment: Results of Two Nationwide, Randomized Survey Studies. Journal of general internal medicine. 2023 Nov 1; 38(14):3134-3143.
  11. Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangou-Khyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cífková R, Lunet N, Gurung MS, Mwangi JK, Martins J, Haghshenas R, Sturua L, Vollmer S, Bärnighausen T, Atun R, Sussman JB, Singh K, Saeedi Moghaddam S, Guwatudde D, Geldsetzer P, Manne-Goehler J, Huffman MD, Davies JI, Flood D. Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries. JAMA. 2023 Aug 22; 330(8):715-724.
  12. Al Rifai M, Taffet GE, Matsushita K, Virani SS, De Lemos J, Khera A, Berry J, Ndumele C, Aguilar D, Sun C, Hoogeveen RC, Selvin E, Ballantyne CM, Nambi V. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. The American journal of cardiology. 2023 Oct 1; 204:295-301.
  13. Frank DA, Johnson AE, Hausmann LRM, Gellad WF, Roberts ET, Vajravelu RK. Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender : A Nationally Representative Cross-Sectional Analysis of Adults in the United States. Annals of internal medicine. 2023 Aug 1; 176(8):1057-1066.
  14. Sandhu AT, Heidenreich PA, Borden W, Farmer SA, Ho PM, Hammond G, Johnson JC, Wadhera RK, Wasfy JH, Biga C, Takahashi E, Misra KD, Joynt Maddox KE, American Heart Association Advocacy Coordinating Committee. Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. 2023 Aug 8; 148(6):543-563.
  15. Chen VL, Song MW, Suresh D, Wadhwani SI, Perumalswami P. Effects of social determinants of health on mortality and incident liver-related events and cardiovascular disease in steatotic liver disease. Alimentary pharmacology & therapeutics. 2023 Sep 1; 58(5):537-545.
  16. Deo SV, Motairek I, Nasir K, Mentias A, Elgudin Y, Virani SS, Rajagopalan S, Al-Kindi S. Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases. JAMA Network Open. 2023 Jul 3; 6(7):e2322727.
  17. Crespo-Ramos G, Bebu I, Krause-Steinrauf H, Hoogendoorn CJ, Fang R, Ehrmann D, Presley C, Naik AD, Katona A, Walker EA, Cherrington A, Gonzalez JS, GRADE Research Group. Emotional distress and cardiovascular disease risk among participants enrolled in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study. Diabetes research and clinical practice. 2023 Sep 1; 203:110808.
  18. Forman DE, Kuchel GA, Newman JC, Kirkland JL, Volpi E, Taffet GE, Barzilai N, Pandey A, Kitzman DW, Libby P, Ferrucci L. Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement. Journal of the American College of Cardiology. 2023 Aug 15; 82(7):631-647.
  19. Reddy KP, Eberly LA, Julien HM, Giri J, Fanaroff AC, Groeneveld PW, Khatana SAM, Nathan AS. Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality. American heart journal. 2023 Oct 1; 264:143-152.
  20. Campbell AA, Taylor KA, Augustine AV, Sherwood A, Wu JQ, Beckham JC, Hoerle JM, VA Mid-Atlantic MIRECC , Ulmer CS. Nightmares: an independent risk factor for cardiovascular disease? Sleep. 2023 Jun 13; 46(6).
  21. Jia X, Buckley L, Sun C, Al Rifai M, Yu B, Nambi V, Virani SS, Selvin E, Matsushita K, Hoogeveen RC, Coresh J, Shah AM, Ballantyne CM. Association of Interleukin-6 and Interleukin-18 with Cardiovascular Disease in Older Adults: Atherosclerosis Risk in Communities Study. European journal of preventive cardiology. 2023 Jun 12; zwad197.
  22. Wang Y, Chen B, Ciaccio EJ, Jneid H, Virani SS, Lavie CJ, Lebovits J, Green PHR, Krittanawong C. Celiac Disease and the Risk of Cardiovascular Diseases. International journal of molecular sciences. 2023 Jun 9; 24(12).
  23. Luo J, Feldman R, Callaway Kim K, Rothenberger S, Korytkowski M, Hernandez I, Gellad WF. Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease. JAMA Network Open. 2023 Jun 1; 6(6):e2317886.
  24. Sayed A, Shazly O, Slipczuk L, Krittanawong C, Baloch F, Virani SS. The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials. Cardiovascular drugs and therapy. 2023 Jun 1.
  25. Vassy JL, Posner DC, Ho YL, Gagnon DR, Galloway A, Tanukonda V, Houghton SC, Madduri RK, McMahon BH, Tsao PS, Damrauer SM, O'Donnell CJ, Assimes TL, Casas JP, Gaziano JM, Pencina MJ, Sun YV, Cho K, Wilson PWF. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program. JAMA cardiology. 2023 Jun 1; 8(6):564-574.
  26. Hussain A, Ramsey D, Lee M, Mahtta D, Khan MS, Nambi V, Ballantyne CM, Petersen LA, Walker AD, Kayani WT, Butler J, Slipczuk L, Rogers JG, Bozkurt B, Navaneethan SD, Virani SS. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC. Heart failure. 2023 Aug 1; 11(8 Pt 1):933-942.
  27. Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, Bahrainy S, Ji Kwak M, Batchelor WB, Forman DE, Rich MW, Kirkpatrick J, Krishnaswami A, Alexander KP, Gerstenblith G, Cawthon P, deFilippi CR, Goyal P. Sarcopenia and Cardiovascular Diseases. Circulation. 2023 May 16; 147(20):1534-1553.
  28. Jain V, Minhas AMK, Ariss RW, Nazir S, Khan SU, Khan MS, Rifai MA, Michos E, Mehta A, Qamar A, Vaughan EM, Vaughan EM, Sperling L, Sperling L, Virani SS, Virani SS. Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019. The American journal of medicine. 2023 Jul 1; 136(7):659-668.e7.
  29. Lindner SR, Balasubramanian B, Marino M, McConnell KJ, Kottke TE, Edwards ST, Cykert S, Cohen DJ. Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW. Journal of the American Board of Family Medicine : JABFM. 2023 May 8; 36(3):462-476.
  30. Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, Hernandez I, Lloyd-Jones DM, King JB, Rao S, Herrick JS, Bress AP, Pandey A. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA cardiology. 2023 May 1; 8(5):443-452.
  31. Gupta K, Balachandran I, Foy J, Hermel M, Latif A, Krittanawong C, Slipczuk L, Baloch F, Samad Z, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference. Current Atherosclerosis Reports. 2023 Jun 1; 25(6):309-321.
  32. Virani SS, Ramsey DJ, Westerman D, Kuebeler MK, Chen L, Akeroyd JM, Gobbel GT, Ballantyne CM, Petersen LA, Turchin A, Matheny ME. Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease. Circulation. 2023 May 2; 147(18):1411-1413.
  33. Krishnamurthi N, Schopfer DW, Shen H, Rohrbach G, Elnaggar A, Whooley MA. Association of Home-Based Cardiac Rehabilitation With Lower Mortality in Patients With Cardiovascular Disease: Results From the Veterans Health Administration Healthy Heart Program. Journal of the American Heart Association. 2023 Mar 7; 12(5):e025856.
  34. Isath A, Kanwal A, Virk HUH, Bandyopadhyay D, Wang Z, Kumar A, Kalra A, Naidu SS, Lavie CJ, Virani SS, Krittanawong C. The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis. Current problems in cardiology. 2023 May 1; 48(5):101593.
  35. Minhas AMK, Jain V, Li M, Ariss RW, Fudim M, Michos ED, Virani SS, Sperling L, Mehta A. Family income and cardiovascular disease risk in American adults. Scientific reports. 2023 Jan 6; 13(1):279.
  36. Polanka BM, Gupta SK, So-Armah KA, Freiberg MS, Zapolski TCB, Hirsh AT, Stewart JC. Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic Review. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2023 Jan 2; 57(1):1-25.
  37. Blair EM, Reale BK, Zahuranec DB, Forman J, Langa KM, Giordani B, Fagerlin A, Kollman C, Whitney RT, Levine DA. Perspectives on Why Patients with Mild Cognitive Impairment Might Receive Fewer Cardiovascular Disease Treatments than Patients with Normal Cognition. Journal of Alzheimer's Disease : Jad. 2023 Jan 1; 91(2):573-584.
  38. Gupta K, Hirsch JR, Kalsi J, Patel V, Gad MM, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions. Current Atherosclerosis Reports. 2023 Jan 1; 25(1):31-41.
  39. Flood D, Brant LCC, Sussman JB. The triglyceride glucose index and cardiovascular disease outcomes. The Lancet. Healthy longevity. 2023 Jan 1; 4(1):e2-e3.
  40. Talha KM, Fonarow GC, Virani SS, Butler J. Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure. Methodist DeBakey cardiovascular journal. 2022 Dec 6; 18(5):40-53.
  41. Valero-Elizondo J, Javed Z, Khera R, Tano ME, Dudum R, Acquah I, Hyder AA, Andrieni J, Sharma G, Blaha MJ, Virani SS, Blankstein R, Cainzos-Achirica M, Nasir K. Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey. Archives of public health = Archives belges de sante publique. 2022 Dec 6; 80(1):248.
  42. Brandt EJ, Chang T, Leung C, Ayanian JZ, Nallamothu BK. Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity in 1999-2018. JAMA cardiology. 2022 Dec 1; 7(12):1218-1226.
  43. Federico LE, Johnson TM, England BR, Wysham KD, George MD, Sauer B, Hamilton BC, Hunter CD, Duryee MJ, Thiele GM, Mikuls TR, Baker JF. Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis. Arthritis care & research. 2023 Apr 1; 75(4):768-777.
  44. Hermel M, Pelter M, Jordan T, Latif A, Gad MM, Slipczuk L, Kalra D, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 European Society of Cardiology Congress. Current Atherosclerosis Reports. 2022 Dec 1; 24(12):981-993.
  45. Henderson K, Kaufman B, Rotter JS, Stearns S, Sueta CAA, Foraker R, Ho PM, Chang PP. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study. BMJ open. 2022 Nov 7; 12(11):e058777.
  46. Peikert A, Claggett BL, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, Bhatt DL, Gaziano JM, Talbot HK, Yancy C, Anand I, Mao L, Cooper LS, Solomon SD, Vardeny O. Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. European journal of heart failure. 2023 Feb 1; 25(2):299-310.
  47. Gaffey AE, Gathright EC, Fletcher LM, Goldstein CM. Screening for Psychological Distress and Risk of Cardiovascular Disease and Related Mortality: A SYSTEMATIZED REVIEW, META-ANALYSIS, AND CASE FOR PREVENTION. Journal of cardiopulmonary rehabilitation and prevention. 2022 Nov 1; 42(6):404-415.
  48. Stewart IJ, Amuan ME, Wang CP, Kennedy E, Kenney K, Werner JK, Carlson KF, Tate DF, Pogoda TK, Dismuke-Greer CE, Wright WS, Wilde EA, Pugh MJ. Association Between Traumatic Brain Injury and Subsequent Cardiovascular Disease Among Post-9/11-Era Veterans. JAMA neurology. 2022 Nov 1; 79(11):1122-1129.
  49. Vardeny O. Influenza vaccine in cardiovascular disease: time to move the needle. European heart journal. 2022 Nov 1; 43(41):4389-4391.
  50. Streed CG, Duncan MS, Heier KR, O'Leary J, Skanderson M, Goulet JL. Cardiovascular Disease Risk and Outcomes Among Veterans by Sexual Orientation. [Abstract]. Circulation. 2022 Nov 8; 146(Suppl_1):A10145.
  51. Hargrave AS, Sumner JA, Ebrahimi R, Cohen BE. Posttraumatic Stress Disorder (PTSD) as a Risk Factor for Cardiovascular Disease: Implications for Future Research and Clinical Care. Current Cardiology Reports. 2022 Dec 1; 24(12):2067-2079.
  52. Otero-Leon DF, Lavieri MS, Denton BT, Sussman J, Hayward RA. Monitoring policy in the context of preventive treatment of cardiovascular disease. Health Care Management Science. 2023 Mar 1; 26(1):93-116.
  53. Writing Committee , Birtcher KK, Allen LA, Anderson JL, Bonaca MP, Gluckman TJ, Hussain A, Kosiborod M, Mehta LS, Virani SS. 2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2023 Jan 24; 81(3):292-317.
  54. Kronenberg F, Kronenberg F, Mora S, Mora S, Stroes ESG, Stroes ESG, Ference BA, Ference BA, Arsenault BJ, Arsenault BJ, Berglund L, Berglund L, Dweck MR, Dweck MR, Koschinsky M, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoglu LS, Catapano AL. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European heart journal. 2022 Oct 14; 43(39):3925-3946.
  55. Sanchez A, Elizondo-Alzola U, Pijoan JI, Mediavilla MM, Pablo S, Sainz de Rozas R, Lekue I, Gonzalez-Larragan S, Llarena M, Larrañaga O, Helfrich CD, Grandes G. Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care. Frontiers in medicine. 2022 Oct 13; 9(1):967887.
  56. Yang B, Glenn AJ, Liu Q, Madsen T, Allison MA, Shikany JM, Manson JE, Chan KHK, Wu WC, Li J, Liu S, Lo K. Added Sugar, Sugar-Sweetened Beverages, and Artificially Sweetened Beverages and Risk of Cardiovascular Disease: Findings from the Women's Health Initiative and a Network Meta-Analysis of Prospective Studies. Nutrients. 2022 Oct 11; 14(20).
  57. Marshall NJ, Lee JL, Schroeder J, Lee WN, See J, Madjid M, Munagala MR, Piette JD, Tan L, Vardeny O, Greenberg M, Liska J, Mercer M, Samson S. Influence of Digital Intervention Messaging on Influenza Vaccination Rates Among Adults With Cardiovascular Disease in the United States: Decentralized Randomized Controlled Trial. Journal of medical Internet research. 2022 Oct 7; 24(10):e38710.
  58. Haji M, Lopes VV, Ge A, Halladay C, Soares C, Shah NR, Longenecker CT, Lally M, Bloomfield GS, Shireman TI, Ross D, Sullivan JL, Rudolph JL, Wu WC, Erqou S. Two decade trends in cardiovascular disease outcomes and cardiovascular risk factors among US veterans living with HIV. International journal of cardiology. Cardiovascular risk and prevention. 2022 Dec 1; 15:200151.
  59. Chevli PA, Islam T, Pokharel Y, Rodriguez F, Virani SS, Blaha MJ, Bertoni AG, Budoff M, Otvos JD, Shapiro MD. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of clinical lipidology. 2022 Sep 19; 16(6):870-877.
  60. Balasubramanian BA, Lindner S, Marino M, Springer R, Edwards ST, McConnell KJ, Cohen DJ. Improving Delivery of Cardiovascular Disease Preventive Services in Small-to-Medium Primary Care Practices. Journal of the American Board of Family Medicine : JABFM. 2022 Sep 12.
  61. Ganatra S, Dani SS, Kumar A, Khan SU, Wadhera R, Neilan TG, Thavendiranathan P, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu JE, Sadler D, Asnani A, Baldassarre LA, Gupta D, Yang E, Guha A, Brown SA, Stevens J, Hayek SS, Porter C, Kalra A, Baron SJ, Ky B, Virani SS, Kazi D, Nasir K, Nohria A. Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States. JACC. CardioOncology. 2022 Sep 1; 4(3):326-337.
  62. Dhruva SS, Dziura J, Bathulapalli H, Rosman L, Gaffey AE, Davis MB, Brandt CA, Haskell SG. Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans. Journal of general internal medicine. 2022 Sep 1; 37(Suppl 3):806-815.
  63. Lewinski AA, Jazowski SA, Goldstein KM, Whitney C, Bosworth HB, Zullig LL. Intensifying approaches to address clinical inertia among cardiovascular disease risk factors: A narrative review. Patient education and counseling. 2022 Dec 1; 105(12):3381-3388.
  64. Olomu A, Kelly-Blake K, Hart-Davidson W, Gardiner J, Luo Z, Heisler M, Holmes-Rovner M. Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial. Trials. 2022 Aug 15; 23(1):659.
  65. Al Rifai M, Al Rifai M, Yao J, Yao J, Guo X, Guo X, Post WS, Post WS, Malik S, Malik S, Blumenthal RS, Blumenthal RS, Ballantyne CM, Budoff M, Taylor KD, Lin HJ, Rich SS, Hajek C, Greenland P, Rotter JI, Virani SS. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Progress in Cardiovascular Diseases. 2022 Aug 8; 74:19-27.
  66. Virani SS. Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already? JAMA Network Open. 2022 Aug 1; 5(8):e2228538.
  67. Jain V, Al Rifai M, Khan SU, Kalra A, Rodriguez F, Samad Z, Pokharel Y, Misra A, Sperling LS, Rana JS, Ullah W, Medhekar A, Virani SS. Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study. Journal of the American Heart Association. 2022 Aug 2; 11(15):e024414.
  68. Al Rifai M, Virani SS, Nambi V. Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention. Journal of the American Heart Association. 2022 Aug 2; 11(15):e026600.
  69. Al Rifai M, Kianoush S, Jain V, Joshi PH, Cainzos-Achirica M, Nasir K, Merchant AT, Dodani S, Wong SS, Samad Z, Mehta A, Chunara R, Kalra A, Virani SS. Association of U.S. birth, duration of residence in the U.S., and atherosclerotic cardiovascular disease risk factors among Asian adults. Preventive medicine reports. 2022 Oct 1; 29:101916.
  70. O'Sullivan JW, Raghavan S, Marquez-Luna C, Luzum JA, Damrauer SM, Ashley EA, O'Donnell CJ, Willer CJ, Natarajan P, American Heart Association Council on Genomic and Precision Medicine; Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2022 Aug 23; 146(8):e93-e118.
  71. Katz AJ, Chen RC, Usinger DS, Danus SM, Zullig LL. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors. Journal of cancer survivorship : research and practice. 2023 Apr 1; 17(2):351-359.
  72. Thompson ZM, Jain V, Chen YH, Kayani W, Patel A, Kianoush S, Medhekar A, Khan SU, George J, Petersen LA, Virani SS, Al Rifai M. State-Level Social Vulnerability Index and Healthcare Access in Patients With Atherosclerotic Cardiovascular Disease (from the BRFSS Survey). The American journal of cardiology. 2022 Sep 1; 178:149-153.
  73. Hogervorst S, Vervloet M, Adriaanse MC, Zamboni K, Zullig LL, Schoonmade L, Hugtenburg JG, van Dijk L. Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review. British journal of clinical pharmacology. 2023 Jul 1; 89(7):1996-2019.
  74. Mohile S, Blaum CS, Abadir PM, Dale W, Forman DE, Fung C, Holmes HM, Moslehi J, Mustian KM, Rich MW, Whitson HE. AGS and NIA bench-to bedside conference summary: Cancer and cardiovascular disease. Journal of the American Geriatrics Society. 2022 Oct 1; 70(10):2764-2774.
  75. Hermel M, Tsai S, Dlouhy L, B K A, Rana JS, Dani SS, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Current Atherosclerosis Reports. 2022 Aug 1; 24(8):671-680.
  76. Denfeld QE, Turrise S, MacLaughlin EJ, Chang PS, Clair WK, Lewis EF, Forman DE, Goodlin SJ, American Heart Association Cardiovascular Disease in Older Populations Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing; Council on Lifestyle and Cardiometabolic Health; and Stroke Council. Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. Cardiovascular quality and outcomes. 2022 Jun 1; 15(6):e000108.
  77. Zullig LL, Drake C, Shahsahebi M, Avecilla RAV, Whitney C, Mills C, Oeffinger KC. Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review. Journal of cancer survivorship : research and practice. 2023 Jun 1; 17(3):595-618.
  78. Dong C, Zhou C, Fu C, Hao W, Ozaki A, Shrestha N, Virani SS, Mishra SR, Zhu D. Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants. Biology of sex differences. 2022 May 7; 13(1):21.
  79. Jain V, Rifai MA, Brinzevich D, Taj M, Saleh M, Krittanawong C, Patel J, Patel A, Lee MT, Mahtta D, Virani SS. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. European journal of preventive cardiology. 2022 Mar 25; 29(3):493-501.
  80. Erqou S, Papaila A, Halladay C, Ge A, Liu MA, Jiang L, Lally M, Menon A, Shah NR, Miech E, Virani SS, Zullo AR, Shireman TI, Longenecker CT, Ross D, Sullivan JL, Wu WC, Rudolph JL. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease. American heart journal. 2022 Jul 1; 249:12-22.
  81. Al Rifai M, Vaughan EM, Abushamat LA, Lee M, Ramsey DJ, Gupta K, Navaneethan SD, Virani SS. Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). The American journal of cardiology. 2022 Jun 1; 172:7-10.
  82. Jain V, Al Rifai M, Turpin R, Eken HN, Agrawal A, Mahtta D, Samad Z, Coulter S, Rodriguez F, Petersen LA, Virani SS. Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2022 Mar 1; 7(3):341-345.
  83. Marcus ME, Manne-Goehler J, Theilmann M, Farzadfar F, Moghaddam SS, Keykhaei M, Hajebi A, Tschida S, Lemp JM, Aryal KK, Dunn M, Houehanou C, Bahendeka S, Rohloff P, Atun R, Bärnighausen TW, Geldsetzer P, Ramirez-Zea M, Chopra V, Heisler M, Davies JI, Huffman MD, Vollmer S, Flood D. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data. The Lancet. Global health. 2022 Mar 1; 10(3):e369-e379.
  84. Ijaz N, Buta B, Xue QL, Mohess DT, Bushan A, Tran H, Batchelor W, deFilippi CR, Walston JD, Bandeen-Roche K, Forman DE, Resar JR, O'Connor CM, Gerstenblith G, Damluji AA. Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2022 Feb 8; 79(5):482-503.
  85. Golaszewski NM, LaCroix AZ, Godino JG, Allison MA, Manson JE, King JJ, Weitlauf JC, Bea JW, Garcia L, Kroenke CH, Saquib N, Cannell B, Nguyen S, Bellettiere J. Evaluation of Social Isolation, Loneliness, and Cardiovascular Disease Among Older Women in the US. JAMA Network Open. 2022 Feb 1; 5(2):e2146461.
  86. Mahtta D, Ramsey DJ, Lee MT, Chen L, Al Rifai M, Akeroyd JM, Vaughan EM, Matheny ME, Santo KRDE, Navaneethan SD, Lavie CJ, Birnbaum Y, Ballantyne CM, Petersen LA, Virani SS. Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 Feb 1; 45(2):372-380.
  87. Hira RS, Gosch KL, Kazi DS, Yeh RW, Kataruka A, Maddox TM, Shah T, Jneid H, Bhatt DL, Virani SS. Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry. Circulation. Cardiovascular quality and outcomes. 2022 Mar 1; 15(3):e007979.
  88. Nasir K, Acquah I, Dey AK, Agrawal T, Hassan SZ, Glassner K, Abraham B, Quigley EMM, Blankstein R, Virani SS, Blaha MJ, Valero-Elizondo J, Cainzos-Achirica M, Mehta NN. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey. American journal of preventive cardiology. 2022 Mar 1; 9:100316.
  89. Al Rifai M, Kanaya AM, Kandula NR, Patel J, Al-Mallah MH, Budoff M, Cainzos-Achirica M, Criqui MH, Virani SS. Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. Current problems in cardiology. 2023 Apr 1; 48(4):101105.
  90. Lee MT, George J, Shahab H, Hermel M, Rana JS, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Current Atherosclerosis Reports. 2022 Jan 1; 24(1):61-72.
  91. Vyas DA, James A, Kormos W, Essien UR. Revising the atherosclerotic cardiovascular disease calculator without race. The Lancet. Digital health. 2022 Jan 1; 4(1):e4-e5.
  92. Al Rifai M, Mahtta D, Ramsey DJ, Lee MT, Krittanawong C, Navaneethan SD, Gregg LP, Petersen LA, Virani SS. Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. American heart journal. 2022 Jun 1; 248:160-162.
  93. Marino M, Solberg L, Springer R, McConnell KJ, Lindner S, Ward R, Edwards ST, Stange KC, Cohen DJ, Balasubramanian BA. Cardiovascular Disease Preventive Services Among Smaller Primary Care Practices. American journal of preventive medicine. 2022 May 1; 62(5):e285-e295.
  94. Al Rifai M, Blaha MJ, Nambi V, Shea SJC, Michos ED, Blumenthal RS, Ballantyne CM, Szklo M, Greenland P, Miedema MD, Nasir K, Rotter JI, Guo X, Yao J, Post WS, Virani SS. Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 Jan 25; 145(4):259-267.
  95. Gobbel GT, Matheny ME, Reeves RR, Akeroyd JM, Turchin A, Ballantyne CM, Petersen LA, Virani SS. Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2022 Mar 1; 9:100300.
  96. Krittanawong C, Khawaja M, Rosenson RS, Amos CI, Nambi V, Lavie CJ, Virani SS. Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy. Current problems in cardiology. 2022 Jul 1; 47(7):101043.
  97. Okunrintemi V, Valero-Elizondo J, Stone NJ, Blankstein R, Blaha MJ, Gulati M, Virani SS, Zoghbi WA, Michos ED, Nasir K. Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015. American journal of preventive cardiology. 2021 Dec 1; 8:100281.
  98. Shams P, Hussain M, Karani S, Mahmood S, Hasan A, Siddiqi S, Virani SS, Samad Z. Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians? Current Cardiology Reports. 2021 Oct 23; 23(12):181.
  99. Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Current Atherosclerosis Reports. 2021 Oct 14; 23(12):76.
  100. Sarraju A, Spencer-Bonilla G, Chung S, Gomez S, Li J, Heidenreich P, Palaniappan L, Rodriguez F. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk. Journal of general internal medicine. 2022 Aug 1; 37(11):2642-2649.
  101. Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A, Virani SS, Gulati M, Lee JS, Reis S, Saba S, Ballantyne C, Mulukutla S. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circulation. Cardiovascular quality and outcomes. 2021 Sep 1; 14(9):e007485.
  102. Chow SL, Sasson C, Benjamin IJ, Califf RM, Compton WM, Oliva EM, Robson C, Sanchez EJ. Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 2021 Sep 28; 144(13):e218-e232.
  103. Monach PA, Branch-Elliman W. Aspirin Dosing in Cardiovascular Disease. The New England journal of medicine. 2021 Aug 19; 385(8):764.
  104. Blumenthal DM, Maddox TM, Aragam K, Sacks CA, Virani SS, Wasfy JH. Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2021 Sep 1; 14(9):e007237.
  105. Mahajan S, Grandhi GR, Valero-Elizondo J, Mszar R, Khera R, Acquah I, Yahya T, Virani SS, Blankstein R, Blaha MJ, Cainzos-Achirica M, Nasir K. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. Journal of the American Heart Association. 2021 Aug 17; 10(16):e020028.
  106. Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SS. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Progress in Cardiovascular Diseases. 2021 Aug 8; 68:2-6.
  107. Bhugra P, Grandhi GR, Mszar R, Satish P, Singh R, Blaha M, Blankstein R, Virani SS, Cainzos-Achirica M, Nasir K. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement. Journal of the American Heart Association. 2021 Aug 3; 10(15):e019671.
  108. Jilani MH, Javed Z, Yahya T, Valero-Elizondo J, Khan SU, Kash B, Blankstein R, Virani SS, Blaha MJ, Dubey P, Hyder AA, Vahidy FS, Cainzos-Achirica M, Nasir K. Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Current Atherosclerosis Reports. 2021 Jul 26; 23(9):55.
  109. Kherallah R, Al Rifai M, Kamat I, Krittanawong C, Mahtta D, Lee MT, Liu J, Nasir K, Valero-Elizondo J, Patel J, Al-Mallah MH, Petersen LA, Virani SS. Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey. Preventive medicine. 2021 Dec 1; 153:106715.
  110. Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, Samad Z, Itchhaporia D, Khan SU, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2021 Jul 1; 6(7):782-790.
  111. Ulmer CS, McCant F, Stechuchak KM, Olsen M, Bosworth HB. Prevalence of insomnia disorder and sleep apnea in a sample of veterans at risk for cardiovascular disease. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2021 Jul 1; 17(7):1441-1446.
  112. Al Rifai M, Jia X, Pickett J, Hussain A, Navaneethan SD, Birtcher KK, Ballantyne C, Petersen LA, Virani SS. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Population health management. 2022 Feb 1; 25(1):39-45.
  113. Chichetto NE, Kundu S, Freiberg MS, Koethe JR, Butt AA, Crystal S, So-Armah KA, Cook RL, Braithwaite RS, Justice AC, Fiellin DA, Khan M, Bryant KJ, Gaither JR, Barve SS, Crothers K, Bedimo RJ, Warner A, Tindle HA, Veterans Aging Cohort Study. Association of Syndemic Unhealthy Alcohol Use, Smoking, and Depressive Symptoms on Incident Cardiovascular Disease among Veterans With and Without HIV-Infection. AIDS and behavior. 2021 Sep 1; 25(9):2852-2862.
  114. Daher M, Al Rifai M, Mahtta D, Krittanawong C, Berman J, Ullah W, Alam M, Virani SS. Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey). The American journal of cardiology. 2021 Aug 1; 152:177-178.
  115. Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, Virani SS, Desai NR, Sasangohar F, Krumholz HM, Esnaola NF, Nasir K. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC. CardioOncology. 2021 Jun 1; 3(2):236-246.
  116. Lowenstern A, Li S, Navar AM, Virani SS, Roger VL, Robinson JG, Goldberg AC, Kampman W, Peterson ED, Wang TY. Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clinical Cardiology. 2021 Jun 1; 44(6):863-870.
  117. Jones WS, Mulder H, Wruck LM, Pencina MJ, Kripalani S, Muñoz D, Crenshaw DL, Effron MB, Re RN, Gupta K, Anderson RD, Pepine CJ, Handberg EM, Manning BR, Jain SK, Girotra S, Riley D, DeWalt DA, Whittle J, Goldberg YH, Roger VL, Hess R, Benziger CP, Farrehi P, Zhou L, Ford DE, Haynes K, VanWormer JJ, Knowlton KU, Kraschnewski JL, Polonsky TS, Fintel DJ, Ahmad FS, McClay JC, Campbell JR, Bell DS, Fonarow GC, Bradley SM, Paranjape A, Roe MT, Robertson HR, Curtis LH, Sharlow AG, Berdan LG, Hammill BG, Harris DF, Qualls LG, Marquis-Gravel G, Modrow MF, Marcus GM, Carton TW, Nauman E, Waitman LR, Kho AN, Shenkman EA, McTigue KM, Kaushal R, Masoudi FA, Antman EM, Davidson DR, Edgley K, Merritt JG, Brown LS, Zemon DN, McCormick TE, Alikhaani JD, Gregoire KC, Rothman RL, Harrington RA, Hernandez AF, ADAPTABLE Team. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. The New England journal of medicine. 2021 May 27; 384(21):1981-1990.
  118. Blalock DV, Grubber J, Smith VA, Zulman DM, Weidenbacher HJ, Greene L, Dedert EA, Maciejewski ML. The association of alcohol use with all-cause and cardiovascular disease-related hospitalizations or death in older, high-risk Veterans. Alcoholism, clinical and experimental research. 2021 Jun 1; 45(6):1215-1224.
  119. Huang M, Lo K, Li J, Allison M, Wu WC, Liu S. Pasta meal intake in relation to risks of type 2 diabetes and atherosclerotic cardiovascular disease in postmenopausal women : findings from the Women's Health Initiative. BMJ nutrition, prevention & health. 2021 Apr 30; 4(1):195-205.
  120. Sajja A, Li HF, Spinelli KJ, Ali A, Virani SS, Martin SS, Gluckman TJ. A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2021 Sep 1; 7:100187.
  121. Tsai S, Nguyen H, Ebrahimi R, Barbosa MR, Ramanan B, Heitjan DF, Hastings JL, Modrall JG, Jeon-Slaughter H. COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans. Scientific reports. 2021 Apr 19; 11(1):8497.
  122. Lee MT, Mahtta D, Chen L, Hussain A, Al Rifai M, Sinh P, Khalid U, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. The American journal of medicine. 2021 Aug 1; 134(8):1047-1051.e2.
  123. Agrawal T, Acquah I, Dey AK, Glassner K, Abraham B, Blankstein R, Virani SS, Blaha MJ, Valero-Elizondo J, Mehta N, Quigley EM, Cainzos-Achirica M, Nasir K. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease. American journal of preventive cardiology. 2021 Jun 1; 6:100171.
  124. Jeon-Slaughter H, Chen X, Tsai S, Ramanan B, Ebrahimi R. Developing an Internally Validated Veterans Affairs Women Cardiovascular Disease Risk Score Using Veterans Affairs National Electronic Health Records. Journal of the American Heart Association. 2021 Feb 23; 10(5):e019217.
  125. Lee MT, Mahtta D, Alam M, Ullah W, Nasir K, Hanif B, Virani SS. Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease. Expert review of pharmacoeconomics & outcomes research. 2021 Aug 1; 21(4):559-570.
  126. Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, Jneid H, Ballantyne C, Petersen LA, Virani SS. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart (British Cardiac Society). 2021 Apr 1; 107(8):650-656.
  127. Pack AI, Magalang UJ, Singh B, Kuna ST, Keenan BT, Maislin G. Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias. Sleep. 2021 Feb 12; 44(2).
  128. Jia X, Lee MT, Ramsey DJ, Al Rifai M, Mahtta D, Krittanawong C, Akeroyd JM, Matheny ME, Gobbel G, Stone NJ, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovascular drugs and therapy. 2022 Apr 1; 36(2):295-300.
  129. Al Rifai M, Khalid U, Misra A, Liu J, Nasir K, Cainzos-Achirica M, Mahtta D, Ballantyne CM, Petersen LA, Virani SS. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. American journal of preventive cardiology. 2021 Mar 1; 5:100150.
  130. Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne CM, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. American journal of preventive cardiology. 2021 Mar 1; 5:100149.
  131. Marrero WJ, Lavieri MS, Sussman JB. Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases. Health Care Management Science. 2021 Mar 1; 24(1):1-25.
  132. Golbus JR, Dempsey W, Jackson EA, Nallamothu BK, Klasnja P. Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2021 Feb 1; 14(2):e006760.
  133. Spencer-Bonilla G, Chung S, Sarraju A, Heidenreich P, Palaniappan L, Rodriguez F. Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease. Journal of the American Geriatrics Society. 2021 Apr 1; 69(4):979-985.
  134. Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovascular drugs and therapy. 2022 Feb 1; 36(1):93-102.
  135. Vardeny O, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, McGeer A, Talbot HK, Anand I, Bhatt DL, Cannon CP, DeMets D, Gaziano JM, Goodman SG, Nichol K, Tattersall MC, Temte JL, Wittes J, Yancy C, Claggett B, Chen Y, Mao L, Havighurst TC, Cooper LS, Solomon SD, INVESTED Committees and Investigators. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. JAMA. 2021 Jan 5; 325(1):39-49.
  136. Grandhi GR, Mszar R, Vahidy F, Valero-Elizondo J, Blankstein R, Blaha MJ, Virani SS, Andrieni JD, Omer SB, Nasir K. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA cardiology. 2021 Jan 1; 6(1):87-91.
  137. Mehta A, Singh S, Saeed A, Mahtta D, Bittner VA, Sperling LS, Virani SS. Pathophysiological Mechanisms Underlying Excess Risk for Diabetes and Cardiovascular Disease in South Asians: The Perfect Storm. Current Diabetes Reviews. 2021 Jan 1; 17(9):e070320183447.
  138. Navar AM, Wang TY, Li S, Mi X, Li Z, Robinson JG, Virani SS, Peterson ED. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. Circulation. Cardiovascular quality and outcomes. 2021 Jan 1; 14(1):e006548.
  139. Saeed A, Virani SS, Mulukutla S, Chow CK. Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Current Diabetes Reviews. 2021 Jan 1; 17(9):e011221190238.
  140. Stapleton P, Siddiqi S, Apaydin EA, Akinniranye O, Becerra A, Gahlon G, Xenakis L, Griswold M, Larkin J. Emerging Technologies and Therapeutics Report: Narrative Review and Evidence Mapping Proteomics for Cancer and Cardiovascular Disease. Patient-Centered Outcomes Research Institute Emerging Technologies and Therapeutics Report. Washington, DC: Patient-Centered Outcomes Research Institute; 2021 Jan 1. 93 p.
  141. Krishnaswami A, Beavers C, Dorsch MP, Dodson JA, Masterson Creber R, Kitsiou S, Goyal P, Maurer MS, Wenger NK, Croy DS, Alexander KP, Batsis JA, Turakhia MP, Forman DE, Bernacki GM, Kirkpatrick JN, Orr NM, Peterson ED, Rich MW, Freeman AM, Bhavnani SP, Innovations, Cardiovascular Team and the Geriatric Cardiology Councils, American College of Cardiology. Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020 Dec 1; 76(22):2650-2670.
  142. Bean-Mayberry BA, Chanfreau CC, Clair K, Schweizer CA, Dyer KE, Brunner JW, Moreau JL, Huynh AK, Moin T, Finley EP, Hamilton AB. Women Veterans' Knowledge of Cardiovascular Disease Risk: Higher Than National Samples and an Opportunity for Innovations. [Abstract]. Circulation. 2020 Nov 12; 142(Suppl_3):Abstract 17395.
  143. Okunrintemi V, Tibuakuu M, Virani SS, Sperling LS, Volgman AS, Gulati M, Cho L, Leucker TM, Blumenthal RS, Michos ED. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. Journal of the American Heart Association. 2020 Dec 15; 9(24):e018764.
  144. Jia X, Al Rifai M, Hussain A, Martin S, Agarwala A, Virani SS. Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Current Atherosclerosis Reports. 2020 Oct 3; 22(12):72.
  145. Tibuakuu M, Okunrintemi V, Savji N, Stone NJ, Virani SS, Blankstein R, Thamman R, Blumenthal RS, Michos ED. Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015. Journal of the American Heart Association. 2020 Oct 20; 9(19):e016744.
  146. Ong SY, Chui P, Bhargava A, Justice A, Hauser RG. Estimating Aspirin Overuse for Primary Prevention of Atherosclerotic Cardiovascular Disease (from a Nationwide Healthcare System). The American journal of cardiology. 2020 Dec 15; 137:25-30.
  147. Ward A, Sarraju A, Chung S, Li J, Harrington R, Heidenreich P, Palaniappan L, Scheinker D, Rodriguez F. Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population. NPJ digital medicine. 2020 Sep 23; 3:125.
  148. Agarwal MA, Ziaeian B, Lavie CJ, Fonarow GC. Cardiovascular Disease in Hospitalizations with a Diagnosis of Coronavirus from Pre-COVID-19 Era in United States: National Analysis from 2016-2017. Mayo Clinic proceedings. 2020 Sep 22; doi: 10.1016/j.mayocp.2020.09.022.
  149. Agarwal MA, Ziaeian B, Lavie CJ, Fonarow GC. Cardiovascular Disease in Hospitalized Patients With a Diagnosis of Coronavirus From the Pre-COVID-19 Era in United States: National Analysis From 2016-2017. Mayo Clinic proceedings. 2020 Dec 1; 95(12):2674-2683.
  150. Liu J, Virani SS, Alam M, Denktas AE, Hamzeh I, Khalid U. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Reviews in medical virology. 2021 May 1; 31(3):e2172.
  151. Westgard B, Martinson BC, Maciosek M, Brown M, Xu Z, Farah F, Ahmed O, Dalmar A, Dubois D, Sanka L, Pryce D. Prevalence of Cardiovascular Disease and Risk Factors Among Somali Immigrants and Refugees. Journal of immigrant and minority health. 2021 Aug 1; 23(4):680-688.
  152. Mizuno A, Changolkar S, Patel MS. Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities. Annual Review of Medicine. 2021 Jan 27; 72:459-471.
  153. Daniel CM, Davila L, Makris UE, Mayo H, Caplan L, Davis L, Solow EB. Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review. ACR open rheumatology. 2020 Sep 1; 2(9):525-532.
  154. Rehman H, Kalra A, Kochar A, Uberoi AS, Bhatt DL, Samad Z, Virani SS. Secondary prevention of cardiovascular diseases in India: Findings from registries and large cohorts. Indian heart journal. 2020 Sep 1; 72(5):337-344.
  155. Raghavan S, Ho YL, Vassy JL, Posner D, Honerlaw J, Costa L, Phillips LS, Gagnon DR, Wilson PWF, Cho K. Optimizing Atherosclerotic Cardiovascular Disease Risk Estimation for Veterans With Diabetes Mellitus. Circulation. Cardiovascular quality and outcomes. 2020 Aug 31; CIRCOUTCOMES120006528.
  156. Okeke NL, Schafer KR, Meissner EG, Ostermann J, Shah AD, Ostasiewski B, Phelps E, Kieler CA, Oladele E, Garg K, Naggie S, Bloomfield GS, Bosworth HB. Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?. Open forum infectious diseases. 2020 Sep 1; 7(9):ofaa361.
  157. Al Rifai M, Shapiro MD, Sayani S, Gulati M, Levine G, Rodriguez F, Mahtta D, Khera A, Petersen LA, Virani SS. Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease. The American journal of cardiology. 2020 Nov 1; 134:146-147.
  158. Song L, Guan T, Guo P, Song F, Van Houtven C, Tan X, Keyserling TC. Cardiovascular disease, risk factors, and health behaviors among cancer survivors and spouses: A MEPS Study. Cancer medicine. 2020 Sep 1; 9(18):6864-6874.
  159. Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Network Open. 2020 Aug 3; 3(8):e2011051.
  160. Mahtta D, Khalid U, Misra A, Samad Z, Nasir K, Virani SS. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Current Atherosclerosis Reports. 2020 Jul 16; 22(9):44.
  161. Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System. JAMA Network Open. 2020 Jul 1; 3(7):e208236.
  162. Mahtta D, Gupta A, Ramsey DJ, Rifai MA, Mehta A, Krittanawong C, Lee MT, Nasir K, Samad Z, Blumenthal RS, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. The American journal of medicine. 2020 Dec 1; 133(12):1424-1432.e1.
  163. Hall KS, Hyde ET, Bassett DR, Carlson SA, Carnethon MR, Ekelund U, Evenson KR, Galuska DA, Kraus WE, Lee IM, Matthews CE, Omura JD, Paluch AE, Thomas WI, Fulton JE. Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia. The international journal of behavioral nutrition and physical activity. 2020 Jun 20; 17(1):78.
  164. Jia X, Al Rifai M, Liu J, Agarwala A, Gulati M, Virani SS. Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Current Atherosclerosis Reports. 2020 Jun 18; 22(8):32.
  165. Muiruri C, Sico IP, Schexnayder J, Webel AR, Okeke NL, Longenecker CT, Gonzalez JM, Jones KA, Gonzales SE, Bosworth HB. Why Do People Living with HIV Adhere to Antiretroviral Therapy and Not Comorbid Cardiovascular Disease Medications? A Qualitative Inquiry. Patient preference and adherence. 2020 Jun 16; 14:985-994.
  166. Mszar R, Grandhi GR, Valero-Elizondo J, Caraballo C, Khera R, Desai N, Virani SS, Blankstein R, Blaha MJ, Nasir K. Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States. Journal of the American Heart Association. 2020 May 18; 9(10):e015523.
  167. Ifidon AM, Agbalajobi O, Essien UR. Improving Racial and Ethnic Minority Representation in Cardiovascular Disease Trials to Advance Health Equity. JAMA cardiology. 2020 May 1; 5(5):611.
  168. Fouayzi H, Ash AS, Rosen AK. A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey. Health services research. 2020 Aug 1; 55(4):568-577.
  169. Virani SS, Smith SC, Stone NJ, Grundy SM. Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia. Circulation. 2020 Apr 7; 141(14):1121-1123.
  170. Liu J, Saeed A, Hussain A, Virani SS. The Way to a Woman's Heart: Assessing, Personalizing, and Reclassifying Atherosclerotic Cardiovascular Disease Risk in Female Patients. Texas Heart Institute journal. 2020 Apr 1; 47(2):125-127.
  171. Khera A, Baum SJ, Gluckman TJ, Gulat M, Martin SS, Michos ED, Navar AM, Taub PR, Toth PP, Virani S, Wong ND, Shapiro MD. Continuity of Care and Outpatient Management for Patients with and at High Risk for Cardiovascular Disease during the COVID-19 Pandemic: A Scientific Statement from the American Society for Preventive Cardiology. American Journal of Preventive Cardiology. 2020 Mar 1; 1(Article 100009):1-29.
  172. Aifah A, Okeke NL, Rentrope CR, Schexnayder J, Bloomfield GS, Bosworth H, Grover K, Hileman CO, Muiruri C, Oakes M, Webel AR, Longenecker CT, Vedanthan R. Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics. Progress in Cardiovascular Diseases. 2020 Mar 1; 63(2):92-100.
  173. Samuel-Hodge CD, Gizlice Z, Allgood SD, Bunton AJ, Erskine A, Leeman J, Cykert S. Strengthening community-clinical linkages to reduce cardiovascular disease risk in rural NC: feasibility phase of the CHANGE study. BMC public health. 2020 Feb 21; 20(1):264.
  174. Inoue K, Ritz B, Brent GA, Ebrahimi R, Rhee CM, Leung AM. Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. JAMA Network Open. 2020 Feb 5; 3(2):e1920745.
  175. Jazowski SA, Bosworth HB, Goldstein KM, White-Clark C, McCant F, Gierisch JM, Zullig LL. Implementing a Population Health Management Intervention to Control Cardiovascular Disease Risk Factors. Journal of general internal medicine. 2020 Jun 1; 35(6):1931-1933.
  176. Cavanagh CE, Rosman L, Chui PW, Bastian L, Brandt C, Haskell S, Burg MM. Barriers to cardiovascular disease preventive behaviors among OEF/OIF/OND women and men veterans. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2020 Apr 1; 39(4):298-306.
  177. Quispe R, Michos ED, Martin SS, Puri R, Toth PP, Al Suwaidi J, Banach M, Virani SS, Blumenthal RS, Jones SR, Elshazly MB. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. Journal of the American Heart Association. 2020 Feb 4; 9(3):e013600.
  178. Schousboe JT, Vo TN, Langsetmo L, Adabag S, Szulc P, Lewis JR, Kats AM, Taylor BC, Ensrud KE. Abdominal aortic calcification (AAC) and ankle-brachial index (ABI) predict health care costs and utilization in older men, independent of prevalent clinical cardiovascular disease and each other. Atherosclerosis. 2020 Feb 1; 295:31-37.
  179. Mehta A, Mahtta D, Gulati M, Sperling LS, Blumenthal RS, Virani SS. Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions. Current Atherosclerosis Reports. 2020 Jan 11; 22(1):3.
  180. Rifai MA, Blaha MJ, Patel J, Xiaoming J, Cainzos-Achirica M, Greenland P, Budoff M, Yeboah J, Nasir K, Al-Mallah MH, Virani SS. Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis). The American journal of cardiology. 2020 Mar 15; 125(6):835-839.
  181. Khera R, Valero-Elizondo J, Das SR, Virani SS, Kash BA, de Lemos JA, Krumholz HM, Nasir K. Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. Circulation. 2019 Dec 17; 140(25):2067-2075.
  182. Jia X, Al Rifai M, Gluckman TJ, Birnbaum Y, Virani SS. Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress. Current Atherosclerosis Reports. 2019 Nov 19; 21(12):46.
  183. Mszar R, Grandhi GR, Valero-Elizondo J, Virani SS, Blankstein R, Blaha M, Mata P, Miname MH, Al Rasadi K, Krumholz HM, Santos RD, Nasir K. Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease. JACC. Cardiovascular imaging. 2020 Apr 1; 13(4):1090-1092.
  184. Bean-Mayberry BA, Chanfreau CC, Schweizer CA, Dyer KE, Brunner JW, Saifu HN, Moreau JL, Huynh AK, Moin T, Finley E, Hamilton AB, Farmer Coste MM. 110: Women Veterans' Health Behaviors, Life Events and Cardiovascular Disease Risks: Targets for Care Innovation. [Abstract]. Clinical Cardiology. 2019 Nov 8; 42(Suppl 2):S36-S50.
  185. Moreau JL, Bean-Mayberry BA, Dyer KE, Finley E, Chanfreau CC, Schweizer CA, Brunner JW, Moin T, Hamilton AB, Farmer Coste MM. 120: Engaging Women Veterans In Cardiovascular Disease Risk Reduction: Provider Perceptions of Patient Barriers to Risk Management. [Abstract]. Clinical Cardiology. 2019 Nov 8; 42(Suppl 2):S36-S50.
  186. Ngo-Metzger Q, Zuvekas S, Shafer P, Tracer H, Borsky AE, Bierman AS. Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal. Journal of the American Board of Family Medicine : JABFM. 2019 Nov 1; 32(6):807-817.
  187. Raghavan S, Ho YL, Kini V, Rhee MK, Vassy JL, Gagnon DR, Cho K, Wilson PWF, Phillips LS. Association Between Early Hypertension Control and Cardiovascular Disease Incidence in Veterans With Diabetes. Diabetes Care. 2019 Oct 1; 42(10):1995-2003.
  188. Vance MC, Wiitala WL, Sussman JB, Pfeiffer P, Hayward RA. Increased Cardiovascular Disease Risk in Veterans With Mental Illness. Circulation. Cardiovascular quality and outcomes. 2019 Oct 1; 12(10):e005563.
  189. Mitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L. A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes. Global heart. 2019 Sep 1; 14(3):215-240.
  190. Song L, Guan T, Guo P, Keyserling TC, Van Houtven C, Tan X. Prevalence of cardiovascular disease and risk factors, quality of life, and health behaviors of cancer survivors and their spouses: findings from MEPS. Journal of cancer survivorship : research and practice. 2019 Oct 1; 13(5):739-748.
  191. Allgood SD, Leeman J, Rosemond CA, Ammerman AS, Samuel-Hodge C, Cykert S. Reducing cardiovascular disease in a rural community. Public health nursing (Boston, Mass.). 2019 Sep 1; 36(5):676-682.
  192. Bick AG, Akwo E, Robinson-Cohen C, Lee K, Lynch J, Assimes TL, DuVall S, Edwards T, Fang H, Freiberg SM, Giri A, Huffman JE, Huang J, Hull L, Kember RL, Klarin D, Lee JS, Levin M, Miller DR, Natarajan P, Saleheen D, Shao Q, Sun YV, Tang H, Wilson O, Chang KM, Cho K, Concato J, Gaziano JM, Kathiresan S, O'Donnell CJ, Rader DJ, Tsao PS, Wilson PW, Hung AM, Damrauer SM, VA Million Veteran Program. Association of Risk Alleles With Cardiovascular Disease in Blacks in the Million Veteran Program. Circulation. 2019 Sep 17; 140(12):1031-1040.
  193. Zullig LL, Smith VA, Lindquist JH, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Cardiovascular disease-related chronic conditions among Veterans Affairs nonmetastatic colorectal cancer survivors: a matched case-control analysis. Cancer management and research. 2019 Jul 22; 11:6793-6802.
  194. Okeke NL, Webel AR, Bosworth HB, Aifah A, Bloomfield GS, Choi EW, Gonzales S, Hale S, Hileman CO, Lopez-Kidwell V, Muiruri C, Oakes M, Schexnayder J, Smith V, Vedanthan R, Longenecker CT. Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD). American heart journal. 2019 Oct 1; 216:91-101.
  195. Quispe R, Elshazly MB, Zhao D, Toth PP, Puri R, Virani SS, Blumenthal RS, Martin SS, Jones SR, Michos ED. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. European journal of preventive cardiology. 2020 Oct 1; 27(15):1597-1605.
  196. Hoerster KD, Campbell S, Dolan M, Stappenbeck CA, Yard S, Simpson T, Nelson KM. PTSD is associated with poor health behavior and greater Body Mass Index through depression, increasing cardiovascular disease and diabetes risk among U.S. veterans. Preventive medicine reports. 2019 Sep 1; 15:100930.
  197. Barghi A, Torres H, Kressin NR, McCormick D. Coverage and Access for Americans with Cardiovascular Disease or Risk Factors After the ACA: a Quasi-experimental Study. Journal of general internal medicine. 2019 Sep 1; 34(9):1797-1805.
  198. Ali S, Dave N, Virani SS, Navaneethan SD. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Current Atherosclerosis Reports. 2019 Jun 22; 21(9):32.
  199. Dindo L, Brandt CP, Fiedorowicz J. Cross-sectional relations between psychological inflexibility and symptoms of depression and anxiety among adults reporting migraines or risk factors for cardiovascular disease. Journal of contextual behavioral science. 2019 Jul 1; 13:1-6.
  200. Shah R, Khan B, Latham SB, Khan SA, Rao SV. A Meta-Analysis of Aspirin for the Primary Prevention of Cardiovascular Diseases in the Context of Contemporary Preventive Strategies. The American journal of medicine. 2019 Nov 1; 132(11):1295-1304.e3.
  201. Rifai MA, Qureshi WT, Dardari Z, Keteyian SJ, Brawner CA, Ehrman JK, Ahmed A, Sakr S, Virani SS, Blaha MJ, Al-Mallah MH. The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project). The American journal of cardiology. 2019 Aug 15; 124(4):511-517.
  202. Al Rifai M, Jia X, Al-Mallah MH, Miedema MD, Martin SS, Virani SS. Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session. Current Atherosclerosis Reports. 2019 May 24; 21(8):31.
  203. Bekelman DB. Improving Primary and Specialist Palliative Care in Cardiovascular Disease. JAMA Network Open. 2019 May 3; 2(5):e192356.
  204. Polanka BM, Kundu S, So-Armah KA, Freiberg MS, Gupta SK, Bedimo RJ, Budoff MJ, Butt AA, Chang CH, Gottlieb SS, Marconi VC, Womack JA, Stewart JC. Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2019 May 1; 81(1):110-117.
  205. Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, Redline S, Wellman A. The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. European heart journal. 2019 Apr 7; 40(14):1149-1157.
  206. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocrine reviews. 2019 Apr 1; 40(2):537-557.
  207. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10; 140(11):e596-e646.
  208. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10; 140(11):e563-e595.
  209. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019 Sep 10; 74(10):1376-1414.
  210. Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2019 Mar 1; 4(3):206-213.
  211. Saban KL, Tell D, Janusek L. Resilience in African American Women at Risk for Cardiovascular Disease: an Exploratory Study. Journal of urban health : bulletin of the New York Academy of Medicine. 2019 Mar 1; 96(Suppl 1):44-49.
  212. Valero-Elizondo J, Khera R, Saxena A, Grandhi GR, Virani SS, Butler J, Samad Z, Desai NR, Krumholz HM, Nasir K. Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology. 2019 Feb 19; 73(6):727-732.
  213. Markossian TW, Kramer HJ, Burge NJ, Pacold IV, Leehey DJ, Huo Z, Schneider J, Ling B, Stroupe KT. Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes. Clinical kidney journal. 2019 Aug 1; 12(4):530-537.
  214. Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circulation. Cardiovascular quality and outcomes. 2019 Jan 1; 12(1):e004817.
  215. Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 Mar 1; 282:52-56.
  216. Schwartz JB, Schmader KE, Hanlon JT, Abernethy DR, Gray S, Dunbar-Jacob J, Holmes HM, Murray MD, Roberts R, Joyner M, Peterson J, Lindeman D, Tai-Seale M, Downey L, Rich MW. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop. Journal of the American Geriatrics Society. 2019 Feb 1; 67(2):371-380.
  217. Donovan LM, Feemster LC, Billings ME, Spece LJ, Griffith MF, Rise PJ, Parsons EC, Palen BN, O'Hearn DJ, Redline S, Au DH, Kapur VK. Risk of Cardiovascular Disease Related to Smoking Is Greater Among Women With Sleep-Disordered Breathing. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2018 Nov 15; 14(11):1929-1935.
  218. Corsi M, Alvarez C, Callahan LF, Cleveland RJ, Golightly YM, Jordan JM, Nelson AE, Renner J, Tsai A, Allen KD. Contributions of symptomatic osteoarthritis and physical function to incident cardiovascular disease. BMC musculoskeletal disorders. 2018 Nov 10; 19(1):393.
  219. Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RS. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 Jun 18; 139(25):e1162-e1177.
  220. Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RS. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Journal of the American College of Cardiology. 2019 Jun 25; 73(24):3153-3167.
  221. Maini R, Wong DB, Addison D, Chiang E, Weisbord SD, Jneid H. Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era. Journal of the American Society of Nephrology : JASN. 2018 Dec 1; 29(12):2782-2786.
  222. Barzilay JI, Buzkova P, Cauley JA, Robbins JA, Fink HA, Mukamal KJ. The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2018 Oct 1; 29(10):2219-2230.
  223. Schousboe JT, Kats AM, Langsetmo L, Vo TN, Taylor BC, Schwartz AV, Cawthon PM, Lewis CE, Barrett-Connor E, Hoffman AR, Orwoll ES, Ensrud KE, Osteoporotic Fractures in Men (MrOS) Study Research Group. Central Obesity and Visceral Adipose Tissue Are Not Associated With Incident Atherosclerotic Cardiovascular Disease Events in Older Men. Journal of the American Heart Association. 2018 Aug 21; 7(16):e009172.
  224. Faza NN, Akeroyd JM, Ramsey DJ, Sha T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani S. Effectiveness of NPs and PAs in Managing Diabetes and Cardiovascular Disease. JAAPA : official journal of the American Academy of Physician Assistants. 2018 Jul 23; 31(7):39-45.
  225. Saban KL, Mathews HL, Bryant FB, Tell D, Joyce C, DeVon HA, Witek Janusek L. Perceived discrimination is associated with the inflammatory response to acute laboratory stress in women at risk for cardiovascular disease. Brain, Behavior, and Immunity. 2018 Oct 1; 73:625-632.
  226. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Jul 17; 320(3):272-280.
  227. Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease. Journal of the American College of Cardiology. 2018 Jul 10; 72(2):156-169.
  228. US Preventive Services Task Force , Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Jul 10; 320(2):177-183.
  229. Faza NN, Akeroyd JM, Ramsey DJ, Shah T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA : official journal of the American Academy of Physician Assistants. 2018 Jul 1; 31(7):39-45.
  230. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Jun 12; 319(22):2308-2314.
  231. Yadlowsky S, Hayward RA, Sussman JB, McClelland RL, Min YI, Basu S. Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk. Annals of internal medicine. 2018 Jul 3; 169(1):20-29.
  232. Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V. Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Current Atherosclerosis Reports. 2018 May 21; 20(7):35.
  233. Marconi VC, Duncan MS, So-Armah K, Re VL, Lim JK, Butt AA, Goetz MB, Rodriguez-Barradas MC, Alcorn CW, Lennox J, Beckman JA, Justice A, Freiberg M. Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study). Journal of the American Heart Association. 2018 May 2; 7(10).
  234. Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. Journal of the American College of Cardiology. 2018 Jun 5; 71(22):2527-2536.
  235. Kalra A, Bhatt DL, Wei J, Anderson KL, Rykowski S, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Virani S. Electronic Health Records and Outpatient Cardiovascular Disease Care Delivery: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Indian heart journal. 2018 Mar 7; https://doi.org/10.1016/j.ihj.2018.03.002.
  236. Zullig LL, McCant F, Silberberg M, Johnson F, Granger BB, Bosworth HB. Changing CHANGE: adaptations of an evidence-based telehealth cardiovascular disease risk reduction intervention. Translational behavioral medicine. 2018 Mar 1; 8(2):225-232.
  237. Rehman H, Samad Z, Mishra SR, Merchant A, Narula JP, Mishra S, Virani S. Epidemiologic Studies Targeting Primary Cardiovascular Disease Prevention in South Asia. Indian heart journal. 2018 Sep 1; 70(5):721-730.
  238. Saeed A, Virani SS. Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein. Frontiers in bioscience (Landmark edition). 2018 Jan 1; 23:1099-1112.
  239. Chang VW, Langa KM, Weir D, Iwashyna TJ. The obesity paradox and incident cardiovascular disease: A population-based study. PLoS ONE. 2017 Dec 7; 12(12):e0188636.
  240. Bosworth HB, Zullig LL. Cancer Survivorship & Cardiovascular Disease. HSR&D Career Development Award Enhancement Initiative [Cyberseminar]. HSR&D. 2017 Nov 14.
  241. Virani SS, Akeroyd JM, Ramsey DJ, Deswal A, Nasir K, Rajan SS, Ballantyne CM, Petersen LA. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Population health management. 2018 Jun 1; 21(3):209-216.
  242. Goldstein KM, Oddone EZ, Bastian LA, Olsen MK, Batch BC, Washington DL. Characteristics and Health Care Preferences Associated with Cardiovascular Disease Risk among Women Veterans. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2017 Nov 1; 27(6):700-706.
  243. Sussman JB, Wiitala WL, Zawistowski M, Hofer TP, Bentley D, Hayward RA. The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use. Medical care. 2017 Sep 1; 55(9):864-870.
  244. Nieuwsma JA, Wray LO, Voils CI, Gierisch JM, Dundon M, Coffman CJ, Jackson GL, Merwin R, Vair C, Juntilla K, White-Clark C, Jeffreys AS, Harris A, Owings M, Marr J, Edelman D. A problem-solving intervention for cardiovascular disease risk reduction in veterans: Protocol for a randomized controlled trial. Contemporary clinical trials. 2017 Sep 1; 60:42-50.
  245. Salami JA, Valero-Elizondo J, Ogunmoroti O, Spatz ES, Rana JS, Virani SS, Blankstein R, Younus A, Arrieta A, Blaha MJ, Veledar E, Nasir K. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey. Journal of the American Heart Association. 2017 Jun 9; 6(6).
  246. Okunrintemi V, Spatz ES, Di Capua P, Salami JA, Valero-Elizondo J, Warraich H, Virani SS, Blaha MJ, Blankstein R, Butt AA, Borden WB, Dharmarajan K, Ting H, Krumholz HM, Nasir K. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. Circulation. Cardiovascular quality and outcomes. 2017 Apr 1; 10(4).
  247. Feldman DI, Valero-Elizondo J, Salami JA, Rana JS, Ogunmoroti O, Osondu CU, Spatz ES, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis. 2017 Mar 1; 258:79-83.
  248. Owens DK. Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF. American Family Physician. 2017 Feb 15; 95(4):222-223.
  249. Goldstein KM, Stechuchak KM, Zullig LL, Oddone EZ, Olsen MK, McCant FA, Bastian LA, Batch BC, Bosworth HB. Impact of Gender on Satisfaction and Confidence in Cholesterol Control Among Veterans at Risk for Cardiovascular Disease. Journal of women's health (2002). 2017 Jul 1; 26(7):806-814.
  250. Maddox TM, Ho PM. Health Services Research in Improving the Delivery of Care for Patients with Cardiovascular Diseases: Moving From Observation to Innovation to Action. Circulation. 2017 Jan 31; 135(5):403-405.
  251. Merchant AT, Virani SS. Evaluating Periodontal Treatment to Prevent Cardiovascular Disease: Challenges and Possible Solutions. Current Atherosclerosis Reports. 2017 Jan 1; 19(1):4.
  252. Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA cardiology. 2017 Jan 1; 2(1):47-54.
  253. Rodriguez F, Lin S, Maron DJ, Knowles JW, Virani SS, Heidenreich PA. Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. American heart journal. 2016 Dec 1; 182:97-102.
  254. Oakes MM, Zullig LL, Davenport CA, Grambow SC, Bosworth HB. Evaluating a Cardiovascular Disease Medication Adherence Program Among Individuals with Low Socioeconomic Status (SES): Study Design and Methodology. Poster session presented at: European Society for Patient Adherence, Compliance and Persistence European Symposium; 2016 Nov 17; Lisbon, Portugal.
  255. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2016 Nov 15; 316(19):1997-2007.
  256. Jones WS, Roe MT, Antman EM, Pletcher MJ, Harrington RA, Rothman RL, Oetgen WJ, Rao SV, Krucoff MW, Curtis LH, Hernandez AF, Masoudi FA. The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. Journal of the American College of Cardiology. 2016 Oct 25; 68(17):1898-1907.
  257. Miedema MD, Virani SS. Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding. Evidence-based medicine. 2016 Dec 1; 21(6):225.
  258. Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB, American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 Nov 22; 134(21):e468-e495.
  259. Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016 Oct 1; 253:156-163.
  260. Valero-Elizondo J, Salami JA, Osondu CU, Ogunmoroti O, Arrieta A, Spatz ES, Younus A, Rana JS, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Economic Impact of Moderate-Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey. Journal of the American Heart Association. 2016 Sep 7; 5(9).
  261. Navar AM, Wang TY, Zakroysky P, Li S, Goldberg A, Virani S, Roger V, Robinson J, Wilson P, Lee LV, Elassal J, Peterson ED. Patient receptiveness to statin therapy is higher when presented with lifetime risk rather than 10-year risk of cardiovascular disease: insights from the PALM registry. Poster session presented at: European Society of Cardiology Annual Scientific Session; 2016 Aug 28; Rome, Italy.
  262. Virani SS, Akeroyd JM, Ramsey DJ, Chan WJ, Frazier L, Nasir K, S Rajan S, Ballantyne CM, Petersen LA. Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. American heart journal. 2016 Nov 1; 181:74-82.
  263. Compher C, Levinson KB, Cambor CL, Stoner N, Boullata JI, Piarulli A, Kinosian B. A Patient With Parenteral Nutrition-Dependent Short Bowel Syndrome and Cardiovascular Disease With 4-Year Exposure to Teduglutide. Jpen. Journal of Parenteral and Enteral Nutrition. 2016 Jul 1; 40(5):725-9.
  264. Stevens J, Erber-Oakkar E, Cui Z, Cai J, Virani SS, Di Angelantonio E, Wormser D. Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines. Obesity (Silver Spring). 2016 Jul 1; 24(7):1554-60.
  265. Cohen DJ, Balasubramanian BA, Gordon L, Marino M, Ono S, Solberg LI, Crabtree BF, Stange KC, Davis M, Miller WL, Damschroder LJ, McConnell KJ, Creswell J. A national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: the ESCALATES study protocol. Implementation science : IS. 2016 Jun 29; 11(1):86.
  266. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT, Pajewski NM, SPRINT Research Group. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged =75 Years: A Randomized Clinical Trial. JAMA. 2016 Jun 28; 315(24):2673-82.
  267. Bibbins-Domingo K, U. S. Preventive Services Task Force. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2016 Jun 21; 164(12):836-45.
  268. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, Heidenreich PA, Huffman MD, Mayosi BM, Mendis S, Murray CJ, Perel P, Piñeiro DJ, Smith SC, Taubert KA, Wood DA, Zhao D, Zoghbi WA. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation. Circulation. 2016 Jun 7; 133(23):e674-90.
  269. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, Heidenreich PA, Huffman MD, Mayosi BM, Mendis S, Murray CJ, Perel P, Piñeiro DJ, Smith SC, Taubert KA, Wood DA, Zhao D, Zoghbi WA. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation. Global heart. 2016 Jun 1; 11(2):251-64.
  270. Miederma MD, Huguelet J, Virani S. Why Don't We Know Who Should Take an Aspirin to Prevent Cardiovascular Disease? Expert Analysis. American College of Cardiology [Internet]. 2016 May 20. Available from: http://www.acc.org/latest-in-cardiology/articles/2016/05/18/09/49/why-dont-we-know-who-should-take-an-aspirin-to-prevent-cvd?w_nav=TI#sthash.7RluB6as.dpuf.
  271. Valle JA, O'Donnell CI, Armstrong EJ, Bradley SM, Maddox TM, Ho PM. Guideline Recommended Medical Therapy for Cardiovascular Diseases in the Obese: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. Journal of the American Heart Association. 2016 May 16; 5(5).
  272. Goldstein K, Oddone EZ, Bastian LA, Mor SS, Washington DL. Characteristics and health care preferences of women veterans at risk for cardiovascular disease. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 13; Hollywood, FL.
  273. Virani S. How Cardiovascular Disease Registries Can Inform Evidence and Science. Paper presented at: University of Alabama at Birmingham Department of Internal Medicine Monthly Grand Rounds; 2016 May 11; Birmingham, AL.
  274. Jacobs JC, Burke S, Rouse M, Sarma S, Zaric G. Cardiovascular Disease Risk Awareness and Its Association With Preventive Health Behaviors: Evidence From a Sample of Canadian Workplaces. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine. 2016 May 1; 58(5):459-65.
  275. Kalra A, Glusenkamp N, Oetgen WJ, Virani SS. Contemporary data on cardiovascular diseases in Indians: American College of Cardiology's PINNACLE India Quality Improvement Program. [Letter to the Editor]. Indian heart journal. 2016 May 1; 68(3):434-5.
  276. Boggan AN, Wang T, Li S, Pencina M, Stafford J, Goldberg A, Robinson J, Roger V, Virani S, Wilson P, Elassal J, Lee V, Petersen E. Patients' Perceived Versus Predicted Cardiovascular Disease Risk: Challenges for Shared Decision-Making in Cholesterol Management. Poster session presented at: American College of Cardiology Annual Scientific Session; 2016 Apr 3; Chicago, IL.
  277. Bilen O, Kamal A, Virani SS. Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions. World journal of cardiology. 2016 Mar 26; 8(3):247-57.
  278. Park LG, Beatty A, Stafford Z, Whooley MA. Mobile Phone Interventions for the Secondary Prevention of Cardiovascular Disease. Progress in Cardiovascular Diseases. 2016 May 1; 58(6):639-50.
  279. Elizondo JV, Salami JA, Osondu C, Younus A, Arrieta A, Spatz ES, Rana JS, Virani S, Blankstein R, Blaha MJ, Veledar E, Nasir K. Economic Impact of Moderate-vigorous Physical Activity Among Those with and without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey. Paper presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  280. Navar AM, Peterson ED, Li S, Virani S, Wilson PW, Robinson JG, Goldberg AC, Roger VL, Elassal J, Lee V, Wang TY. Are Patients with Atherosclerotic Cardiovascular Disease Receiving Appropriate Lipid Management? Insights from the PALM Registry. Poster session presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  281. Salami A, Valero-Elizondo J, Ogunmoroti O, Spatz ES, Rana JS, Virani S, Blankstein R, Blaha MJ, Post J, Arrieta A, Veledar E, Nasir K. Interplay of Health-Related Quality of Life, Cardiovascular Disease and Healthcare Costs: 2012 Medical Expenditure Panel Survey. Poster session presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  282. Salami A, Valero-Elizondo J, Osondu CU, Ogunmoroti O, Post JM, Younus A, Latif MA, Ahmed R, Arrieta A, Spatz ES, Rana JS, Virani S, Blankstein R, Blaha MJ, Veledar E, Nasir K. Per Capita Proportion of Total Health Care Expenditures on Pharmaceuticals Among US Adults With Cardiovascular Disease: 2012 Medical Expenditure Panel Survey. Poster session presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  283. Valero-Elizondo J, Salami JA, Ogunmoroti O, Ali S, Arrieta A, Spatz ES, Rana JS, Virani S, Blankstein R, Blaha MJ, Veledar E, Nasir K. Sex-based Differences in Economic and Health-related Burden of Depression on Adults With Cardiovascular Disease. Poster session presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  284. Agarwala A, Kajani Z, Miedema MD, Virani SS. The Role of Ezetimibe in the Treatment of Cardiovascular Disease. Current Atherosclerosis Reports. 2016 Feb 1; 18(2):8.
  285. Rissling MB, Gray KE, Ulmer CS, Martin JL, Zaslavsky O, Gray SL, Hale L, Zeitzer JM, Naughton M, Woods NF, LaCroix A, Calhoun PS, Stefanick M, Weitlauf JC. Sleep Disturbance, Diabetes, and Cardiovascular Disease in Postmenopausal Veteran Women. The Gerontologist. 2016 Feb 1; 56 Suppl 1:S54-66.
  286. Miedema MD, Huguelet J, Virani SS. Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity. Current Atherosclerosis Reports. 2016 Jan 1; 18(1):4.
  287. So-Armah K, Tate J, Lim JK, Lo Re V, Marconi V, Samet J, Gibert C, Leaf D, Butt A, Goetz MB, Rimland D, Rodriguez-Barradas M, Budoff M, Chang CC, Justice AC, Freiberg MS. Liver injury is associated with total cardiovascular disease, heart failure, stroke, coronary heart disease and acute myocardial infarction including among those without viral hepatitis (B or C), HIV, alcohol abuse and obesity. Paper presented at: American Heart Association Annual Scientific Sessions; 2015 Nov 16; Orlando, FL.
  288. So-Armah K, Tate J, Lim JK, Lo Re V, Marconi V, Samet J, Gibert C, Leaf D, Butt A, Goetz MB, Rimland D, Rodriguez-Barradas M, Budoff M, Chang CC, Justice AC, Freiberg MS. Liver Injury Independently Predicts Incident Cardiovascular Disease (CVD) Risk. Poster session presented at: American Association for the Study of Liver Diseases Annual Meeting; 2015 Nov 14; San Francisco, CA.
  289. So-Armah K, Tate J, Lim J, Lo Re V, Marconi V, Samet J, Gibert C, Leaf D, Butt A, Goetz MB, Rimland D, Rodriguez-Barradas M, Budoff M, Chang C, Justice A, Freiberg M. Liver Injury is Associated With Total Cardiovascular Disease, Heart Failure, Stroke, Coronary Heart Disease and Acute Myocardial Infarction Including Among Those Without Viral Hepatitis (B Or C), HIV, Alcohol Abuse and Obesity. Paper presented at: American Heart Association Scientific Sessions Late-Breaking Clinical Trial Report; 2015 Nov 7; Orlando, FL.
  290. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch SA, Oetgen WJ, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. Journal of the American College of Cardiology. 2015 Oct 20; 66(16):1803-12.
  291. Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World journal of diabetes. 2015 Oct 10; 6(13):1246-58.
  292. Bradley SM, Rumsfeld JS. Depression and cardiovascular disease. Trends in cardiovascular medicine. 2015 Oct 1; 25(7):614-22.
  293. Barbaresso M, Nord KM, Lai Z, Bramlet M, Verchinna L, Kilbourne AM. Reduced Cardiovascular Disease Risk among Veterans with Serious Mental Illness: 12-Month Results from SMI Life Goals Randomized Trial. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 10; Philadelphia, PA.
  294. Rissling M, Gray K, Martin J, Ulmer C, Calhoun PS, Gray SL, Hale L, LaCroix A, Naughton M, Stefanick M, Woods NF, Zaslavsky O, Zeitzer JM, Weitlauf JC. Sleep Disturbance, Diabetes, and Cardiovascular Disease in Post-Menopausal Veteran and non-Veteran Women (Abstract #1171). [Abstract]. Sleep. 2015 Jul 1; 38(Abstract Supplement, 2015):A416.
  295. Rissling M, Gray K, Gerber MR, Harrington LB, Woods NF, Weitlauf JC. Sleep Disturbance, Diabetes, and Cardiovascular Disease in Post-Menopausal Veteran and non-Veteran Women. Paper presented at: American Academy of Sleep Medicine / Sleep Research Society Annual SLEEP Meeting; 2015 Jun 6; Seattle, WA.
  296. Ulmer CS, Bosworth HB, Germain A, Lindquist J, Olsen M, Brancu M, VA Mid-Atlantic Mental Illness Research Education and Clinical Center Registry Workgroup, Beckham JC. Associations between sleep difficulties and risk factors for cardiovascular disease in veterans and active duty military personnel of the Iraq and Afghanistan conflicts. Journal of behavioral medicine. 2015 Jun 1; 38(3):544-55.
  297. Kalra A, Pokharel Y, Hira RS, Risch S, Vicera V, Li Q, Kalra RN, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Glusenkamp N, Turakhia MP, Virani SS. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights From the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Journal of the American Heart Association. 2015 May 20; 4(5).
  298. Corrales-Medina VF, Alvarez KN, Yende S. Hospitalization for pneumonia and risk of cardiovascular disease--reply. JAMA : the journal of the American Medical Association. 2015 May 5; 313(17):1753-4.
  299. Brenes-Salazar JA, Alshawabkeh L, Schmader KE, Hanlon JT, Forman DE. Clinical pharmacology relevant to older adults with cardiovascular disease. Journal of geriatric cardiology : JGC. 2015 May 1; 12(3):192-5.
  300. Virani S, Akeroyd JM, Ramsey D, Chan W, Rajan S, Ballantyne CM, Petersen LA. Comparative Effectiveness of Outpatient Cardiovascular Disease Care Delivery Between Physician and Non-Physician Primary Care Providers: Implications for Care Under the Affordable Care Act. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2015 Apr 29; Baltimore, MD.
  301. Kalra A, Pokharel Y, Hira RS, Risch S, Vicera V, Li Q, Kalra R, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Glusenkamp N, Turakhia MP, Virani SS. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). Poster session presented at: American Association of Cardiologists of Indian Origin Annual Scientific Session; 2015 Mar 15; San Diego, CA.
  302. Stevens J, Erber-Oakkar E, Cui Z, Cai J, Wormser D, Virani SS. 2013 AHA/ACC/TOS and 1998 NHLBI Clinical Guidelines for the Management of Overweight and Obesity Predict Higher Cardiovascular Disease Risk in Adults Recommended versus Not Recommended for Weight Loss Treatment: the Atherosclerosis Risk in Communities Study. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2015 Mar 5; Orlando, FL.
  303. Virani S. Frequency and Practice-Level Variation in Inappropriate Aspirin Use for the Primary Prevention of Cardiovascular Disease Insights From the National Cardiovascular Disease Registry’s Practice Innovation and Clinical Excellence Registry. 2015 Feb 18.
  304. Liu KD, Yang W, Go AS, Anderson AH, Feldman HI, Fischer MJ, He J, Kallem RR, Kusek JW, Master SR, Miller ER, Rosas SE, Steigerwalt S, Tao K, Weir MR, Hsu CY, CRIC Study Investigators. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2015 Feb 1; 65(2):267-74.
  305. Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, Rimland D, Bedimo R, Goetz MB, Rodriguez-Barradas MC, Crane HM, Gibert CL, Brown ST, Tindle HA, Warner AL, Alcorn C, Skanderson M, Justice AC, Freiberg MS. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. Journal of acquired immune deficiency syndromes (1999). 2015 Feb 1; 68(2):209-16.
  306. Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CC, Newman A, Loehr L, Folsom AR, Elkind MS, Lyles MF, Kronmal RA, Yende S. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015 Jan 20; 313(3):264-74.
  307. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. Journal of the American College of Cardiology. 2015 Jan 20; 65(2):111-21.
  308. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. The American journal of cardiology. 2015 Jan 1; 115(1):21-6.
  309. Hayes SM, Alosco ML, Forman DE. The Effects of Aerobic Exercise on Cognitive and Neural Decline in Aging and Cardiovascular Disease. Current geriatrics reports. 2014 Dec 1; 3(4):282-290.
  310. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch S, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry. Paper presented at: American Heart Association Annual Scientific Forum; 2014 Nov 19; Chicago, IL.
  311. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho M, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and Practice-Level Variation In Inappropriate Aspirin Use for Primary Prevention of Cardiovascular Disease: Insights from the NCDR®PINNACLE Registry. Poster session presented at: American Heart Association Annual Scientific Sessions; 2014 Nov 15; Chicago, IL.
  312. LeFevre ML, U. S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2014 Oct 21; 161(8):587-93.
  313. Womack JA, Chang CC, So-Armah KA, Alcorn C, Baker JV, Brown ST, Budoff M, Butt AA, Gibert C, Goetz MB, Gottdiener J, Gottlieb S, Justice AC, Leaf D, McGinnis K, Rimland D, Rodriguez-Barradas MC, Sico J, Skanderson M, Tindle H, Tracy RP, Warner A, Freiberg MS. HIV infection and cardiovascular disease in women. Journal of the American Heart Association. 2014 Oct 16; 3(5):e001035.
  314. Saban KL, Mathews HL, DeVon HA, Janusek LW. Epigenetics and social context: implications for disparity in cardiovascular disease. Aging and disease. 2014 Oct 1; 5(5):346-55.
  315. Bajaj A, Stone KL, Peters K, Parimi N, Barrett-Connor E, Bauer D, Cawthon PM, Ensrud KE, Hoffman AR, Orwoll E, Schernhammer ES. Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. The Journal of clinical endocrinology and metabolism. 2014 Sep 1; 99(9):3256-62.
  316. Goldstein KM, Melnyk SD, Zullig LL, Stechuchak KM, Oddone E, Bastian LA, Rakley S, Olsen MK, Bosworth HB. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2014 Sep 1; 24(5):477-83.
  317. Gerber M, Iverson KM, King M, Haskell S. Associations between mental health burden, smoking, and cardiovascular disease in women Veterans over age 45. Poster session presented at: VA Women's Health Research Conference; 2014 Jul 15; Arlington, VA.
  318. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho M, Deswal A, Ballentyne CM, Petersen LA, Virani S. Frequency and Practice-Level Variation In Inappropriate Aspirin Use for Primary Prevention of Cardiovascular Disease: Insights from the NCDR®PINNACLE Registry. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2014 Jun 3; Baltimore, MD.
  319. Valle J, Maddox TM. The Sex Gap among Cardiovascular Disease Encounters in India. Poster session presented at: Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Annual Scientific Forum; 2014 Jun 2; Baltimore, MD.
  320. Goldstein K, Melnyk SD, Zullig LL, Stechuchak KM, Oddone EZ, Bastian L, Rakley S, Olsen MK, Bosworth HB. Gender and Racial Differences in Control of Cardiovascular Disease Risk Factors among Veterans. Poster session presented at: VA Durham VAMC Annual Research Week; 2014 May 13; Durham, NC.
  321. Turakhia M. Autonomics, Arrhythmias, and HF: Managing the Intersection of Complex Cardiovascular Disease - Chair, Joint Session. Presented at: Heart Rhythm Society Annual Scientific Sessions; 2014 May 7; San Francisco, CA.
  322. Pokharel Y, Sun W, Virani S, Nambi V, Jones PH, Ballantyne CM, Hoogeveen RC. Association of Combination of Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein-Associated Phospholipase A2 with Cardiovascular Disease and Carotid Plaque Characteristics in the Atherosclerosis Risk in Communities Study. Poster session presented at: National Lipid Association Annual Scientific Sessions; 2014 May 2; Orlando, FL.
  323. Heidenreich PA. Cardiovascular Disease Prevention Guidelines 2014. Paper presented at: VA Palo Alto Health Care System Internal Medicine Seminar; 2014 May 1; Palo Alto, CA.
  324. Virani S. Effectiveness, Efficiency, Safety, and Equity in the Delivery of Cardiovascular Care: Lessons Learned from the Department of Veterans Affairs and National Cardiovascular Disease Registries. Paper presented at: VA HSR&D Informatics, Decision-Enhancement and Analytic Sciences Center Annual Meeting; 2014 Apr 24; Salt Lake City, UT.
  325. Goldstein K, Melnyk SD, Zullig LL, Stechuchak KM, Oddone EZ, Bastian L, Rakley S, Olsen MK, Bosworth HB. Gender and Racial Differences in Control of Cardiovascular Disease Risk Factors Among Veterans. Poster session presented at: Society of General Internal Medicine Midwest Regional Annual Meeting; 2014 Apr 23; San Diego, CA.
  326. Moyer VA, U. S. Preventive Services Task Force. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement. Annals of internal medicine. 2014 Apr 15; 160(8):558-64.
  327. Virani S. The interface of Epidemiology and Health Services Research in Cardiovascular Disease. Presented at: University of Texas Southwestern Medical Center Visiting Scholar Quarterly Seminar; 2014 Apr 9; Dallas, TX.
  328. Justice AC, Womack JA. HIV infection and the risk of cardiovascular disease in women. Poster session presented at: Retroviruses and Opportunistic Infections Annual Conference; 2014 Mar 3; Boston, MA.
  329. Hanks D. Emerging Evidence-2: Improving the Health and Care for Veterans with Cardiovascular Disease. 2014 Feb 27; 5(2).
  330. Martin SS, Blaha MJ, Blankstein R, Agatston A, Rivera JJ, Virani SS, Ouyang P, Jones SR, Blumenthal RS, Budoff MJ, Nasir K. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014 Jan 7; 129(1):77-86.
  331. Zullig LL, Melnyk SD, Stechuchak KM, McCant F, Danus S, Oddone E, Bastian L, Olsen M, Edelman D, Rakley S, Morey M, Bosworth HB. The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2014 Feb 1; 20(2):135-43.
  332. Virani S, Woodard LD, Ramsey DJ, Urech TH, Shah T, Bozkurt B, Ballantyne CM, Petersen LA. Are women with cardiovascular disease less likely to receive evidence based statin therapy compared with men? An analysis from a national cohort. Poster session presented at: American Heart Association Annual Scientific Sessions; 2013 Nov 18; Dallas, TX.
  333. Egede LE, Ogburu-Obonnaya AN, Strom Williams J, Lynch C. The effects of generalized anxiety and stress on cardiovascular disease and self-care behaviors in patients with type II diabetes. Poster session presented at: Medical University of South Carolina College of Graduate Studies Perry V. Halushka Annual Research Day; 2013 Nov 7; Charleston, SC.
  334. Bavinger C, Bendavid E, Niehaus K, Olshen RA, Olkin I, Sundaram V, Wein N, Holodniy M, Hou N, Owens DK, Desai M. Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. PLoS ONE. 2013 Sep 30; 8(3):e59551.
  335. Moyer VA, U. S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2013 Sep 3; 159(5):342-8.
  336. Nanchen D, Rodondi N, Cornuz J, Hillier T, Ensrud KE, Cauley JA, Bauer DC, Study of Osteoporotic Fractures Research Group. Mortality associated with diabetes and cardiovascular disease in older women. PLoS ONE. 2013 Jul 11; 7(11):e48818.
  337. Kilbourne AM, Goodrich DE, Lai Z, Post EP, Schumacher K, Nord KM, Bramlet M, Chermack S, Bialy D, Bauer MS. Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT). The Journal of clinical psychiatry. 2013 Jul 1; 74(7):e655-62.
  338. Rahman I, Humphreys K, Bennet AM, Ingelsson E, Pedersen NL, Magnusson PK. Clinical depression, antidepressant use and risk of future cardiovascular disease. European journal of epidemiology. 2013 Jul 1; 28(7):589-95.
  339. Vimalananda VG, Miller DR, Christiansen CL, Wang W, Tremblay P, Fincke BG. Cardiovascular disease risk factors among women veterans at VA medical facilities. Journal of general internal medicine. 2013 Jul 1; 28 Suppl 2:S517-23.
  340. Taber DJ, Pilch NA, Meadows HB, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK, Egede LE. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. Journal of cardiovascular pharmacology and therapeutics. 2013 May 1; 18(3):243-50.
  341. Heisler M, Choi H, Piette JD, Rosland A, Langa KM, Brown S. Adults with cardiovascular disease who help others: a prospective study of health outcomes. Journal of behavioral medicine. 2013 Apr 1; 36(2):199-211.
  342. Virani SS. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Texas Heart Institute journal. 2013 Jan 1; 40(3):288-9.
  343. Kilbourne AM, Goodrich DE, Lai Z, Clogston J, Waxmonsky J, Bauer MS. Life Goals Collaborative Care for patients with bipolar disorder and cardiovascular disease risk. Psychiatric services (Washington, D.C.). 2012 Dec 1; 63(12):1234-8.
  344. Papak J, Kansagara D. Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease. The American journal of cardiology. 2012 Nov 6; 110(9 Suppl):24B-31B.
  345. Egede LE, Strom J. Gender Differences in Composite Control of Cardiovascular Disease. Poster session presented at: National Institutes of Health Science of Eliminating Health Disparities Annual Summit; 2012 Oct 31; Baltimore, MD.
  346. French DD, Margo CE, Harman LE. Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study. North American journal of medical sciences. 2012 Oct 1; 4(10):468-73.
  347. Moyer VA, U. S. Preventive Services Task Force. Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2012 Sep 4; 157(5):367-71.
  348. Nguyen PK, Nag D, Wu JC. Molecular Imaging of Cardiovascular Disease. In: Patterson C, Willis MS, editors. Translational Cardiology: Molecular Basis of Cardiac Metabolism, Cardiac Remodeling, Translational Therapies and Imaging Techniques (Molecular and Translational Medicine). New York, NY: Humana Press, Springer Science+Business Media; 2012. Chapter 14. 485-532 p.
  349. Selby JV, Schmittdiel JA, Fireman B, Jaffe M, Ransom LJ, Dyer W, Uratsu CS, Reed ME, Kerr EA, Hsu J. Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial. BMC health services research. 2012 Jul 2; 12:183.
  350. Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, Schumacher K, Bramlet M, Welsh DE, Bauer MS. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemporary clinical trials. 2012 Jul 1; 33(4):666-78.
  351. Cortes T, Kilbourne AM. Reducing the Mortality Gap: Implementing Integrated Programs to Reduce Cardiovascular Disease Risk among Persons with Mental Disorders. Paper presented at: Michigan Association of Community Mental Health Board Spring Conference; 2012 May 23; Dearborn, MI.
  352. Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI. Prior cardiovascular disease is associated with increased short and long-term mortality in COPD patients with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  353. Slomka JM, Piette JD, Post EP, Krein SL, Lai Z, Goodrich DE, Kilbourne AM. Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder. Journal of affective disorders. 2012 May 1; 138(3):405-8.
  354. Dadu RT, Dodge R, Nambi V, Virani S, Hoogeveen RC, Pankow JS, Coresh J, Guild C, Tang WH, Boerwinkle E, Hazen SL, Ballantyne CM. Ceruloplasmin and cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference; 2012 Apr 18; Chicago, IL.
  355. Saban KL, Bryant FB, Hoppensteadt D, DeVon HA. Social Determinants are Associated with Heat Shock Protein-70 in African American and Non-Hispanic White Women with Cardiovascular Disease. Poster session presented at: American Heart Association / American Stroke Association International Stroke Conference; 2012 Feb 1; New Orleans, LA.
  356. DeVon HA, Saban KL. Psychosocial and biological stressors and the pathogenesis of cardiovascular disease. In: Hill Rice V, editor. Handbook of Stress, Coping, and Health: Implications for Nursing Research, Theory, and Practice. 2nd ed. Thousand Oaks, CA: Sage Publications; 2011. Chapter 15. 381-418 p.
  357. Fischer M, Jordan N, Xie D, Ford V, Krousel-Wood M, Kurella TM, Kusek JW, Rosen L, Strauss LF, Teal VL, Yaffe K, Kop WJ, Powe NR, Lash JP. Depressive Symptoms, Cardiovascular Disease (CVD) Risk Factors, and Subclinical CVD among Individuals in the Chronic Renal Insufficiency Cohort (CRIC) Study. Poster session presented at: American Society of Nephrology Annual Meeting; 2011 Nov 10; Philadelphia, PA.
  358. Ulmer CS, Bosworth HB, MIRREC Registry WG, Germain A, Beckham JC. Sleep Disturbance in Veterans of the Iraq and Afghanistan Conflicts: A Cardiovascular Disease Risk Factor? [Editorial]. Sleep. 2011 Nov 1; 34(Suppl):A242,0703.
  359. Virani SS, Woodard LD, Chitwood SS, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. American heart journal. 2011 Oct 1; 162(4):725-732.e1.
  360. Ricardo AC, Lash JP, Fischer MJ, Lora CM, Budoff M, Keane MG, Kusek JW, Martinez M, Nessel L, Stamos T, Ojo A, Rahman M, Soliman EZ, Yang W, Feldman HI, Go AS, CRIC and HCRIC Investigators. Cardiovascular Disease Among Hispanics and Non-Hispanics in the Chronic Renal Insufficiency Cohort (CRIC) Study. Clinical journal of the American Society of Nephrology : CJASN. 2011 Sep 1; 6(9):2121-2131.
  361. Sabahi I, Richards JS, Mikuls TR, Rangan B, Reimold A, Cannon GW, Johnson D, Caplan L, Kerr GS. Association of Cardiovascular Disease with the Metabolic Syndrome in a Predominantly Male Cohort with Rheumatoid Arthritis. In: Rheumatoid Arthritis / Book 1. Rijeka, Croatia: InTech Open Access Publisher; 2011. ? ? p.
  362. Ulmer CS, Bosworth HB, Germain A, Beckham JC. Sleep Disturbance in Veterans of the Iraq and Afghanistan Conflicts: A Cardiovascular Disease Risk Factor? Paper presented at: Associated Professional Sleep Societies, LLC Annual Meeting; 2011 Jun 11; Minneapolis, MN.
  363. Virani S, Woodard LD, Sookanan S, Landrum CR, Urech TH, Wang D, Murawsky J, Ballantyne CM, Petersen LA. Frequency and correlates of low-density lipoprotein cholesterol (LDL-C) control and treatment intensification in patients with cardiovascular disease. Poster session presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2011 May 12; Washington, DC.
  364. Goodrich DE, Kilbourne AM, Burghardt AR, Post EP, Schumacher K, Bramlet P, Lai Z, Bauer M. Randomized Trial Testing a Chronic Care Model to Reduce Cardiovascular Disease Risk in Patients with Bipolar Disorder. Poster session presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2011 Apr 7; Washington, DC.
  365. Nambi V, Saunders J, Chambless L, de Lemos JA, Liu X, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Folsom AR, Coresh J, Ballantyne CM. High sensitivity troponin is associated with mortality, coronary heart disease, and heart failure in individuals with prevalent cardiovascular disease in the atherosclerosis risk in communities (ARIC Study). Paper presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  366. Paudel ML, Taylor BC, Ancoli-Israel S, Stone KL, Tranah G, Redline S, Barrett-Connor E, Stefanick ML, Ensrud KE. Rest/activity rhythms and cardiovascular disease in older men. Chronobiology International. 2011 Apr 1; 28(3):258-66.
  367. Schmittdiel J, Selby JV, Swain B, Daugherty SL, Leong TK, Ho M, Margolis KL, O'Connor P, Magid DJ, Bibbins-Domingo K. Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011 Apr 1; 57(4):717-22.
  368. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee, Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011 Mar 1; 123(8):933-44.
  369. Rosas SE. Chronic kidney disease in individuals with cardiovascular disease. Paper presented at: National Hispanic Medical Association Annual Conference; 2011 Mar 1; Washington, DC.
  370. Rubin MF, Rosas SE, Chirinos JA, Townsend RR. Surrogate markers of cardiovascular disease in CKD: what's under the hood? American journal of kidney diseases : the official journal of the National Kidney Foundation. 2011 Mar 1; 57(3):488-97.
  371. Ulmer CS, Bosworth HB, Beckham JC. Sleep disturbance in Veterans with PTSD: A cardiovascular disease risk factor reduced with behavioral sleep interventions. Poster session presented at: VA HSR&D Career Development Annual Meeting; 2011 Feb 16; National Harbor, MD.
  372. Virani S, Woodard LD, Landrum C, Wang D, Ballantyne CM, Petersen LA. Frequency and predictors of low-density lipoprotein cholesterol (LDL-C) control and appropriate follow-up care to elevated LDL-C levels in patients with cardiovascular disease. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 16; Washington, DC.
  373. Adeseun G, Xie D, Wang X, Mohler E, Budoff M, Townsend R, Rosas SE. Carotid plaque, carotid intima media thickness, and coronary calcification are comparable predictors of prevalent cardiovascular disease: a report from the chronic renal insufficiency cohort. Presented at: American Society of Nephrology Renal Week Annual Meeting; 2010 Nov 18; Denver, CO.
  374. Rumsfeld JS. Screening, Recognition and Management of Depression in Patients with Cardiovascular Disease. Paper presented at: American Heart Association Annual Scientific Sessions; 2010 Nov 13; Chicago, IL.
  375. Bagnell ME, Granado NS, Boyko EJ, Smith B, Ulmer CS, Smith TC. Posttraumatic stress disorder and cardiovascular disease: a prospective US military cohort study. Paper presented at: Force Health Protection Annual Conference; 2010 Aug 15; Phoenix, AZ.
  376. Bagnell M, Granado N, Boyko E, Smith B, Ulmer CS, Smith T. Posttraumatic Stress Disorder and Cardiovascular Disease: A Prospective US military cohort study. Poster session presented at: American Public Health Association Annual Meeting and Exposition; 2010 Aug 7; Phoenix, AZ.
  377. Zeber J, Parchman ML. Cardiovascular disease in type 2 diabetes: Attributable risk due to modifiable risk factors. Canadian Family Physician Medecin De Famille Canadien. 2010 Aug 1; 56(8):e302-7.
  378. Shikany JM, Tinker LF, Neuhouser ML, Ma Y, Patterson RE, Phillips LS, Liu S, Redden DT. Association of glycemic load with cardiovascular disease risk factors: the Women's Health Initiative Observational Study. Nutrition (Burbank, Los Angeles County, Calif.). 2010 Jun 1; 26(6):641-7.
  379. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Annals of internal medicine. 2010 Apr 20; 152(8):481-7, W170-3.
  380. Rosas SE. Kidney and cardiovascular disease in minority populations. Paper presented at: National Kidney Foundation Clinical Spring Meeting; 2010 Apr 14; Orlando, FL.
  381. Ho M. Importance of Medication Adherence in Cardiovascular Disease. Paper presented at: Montana Cardiovascular Health Summit; 2010 Apr 9; Missoula, MT.
  382. Crosson JC, Heisler M, Subramanian U, Swain B, Davis GJ, Lasser N, Ross S, Schmittdiel JA, Onyemere K, Tseng CW. Physicians' perceptions of barriers to cardiovascular disease risk factor control among patients with diabetes: results from the translating research into action for diabetes (TRIAD) study. Journal of the American Board of Family Medicine. 2010 Mar 1; 23(2):171-8.
  383. Schnipper JL, Roumie CL, Cawthon C, Businger A, Dalal AK, Mugalla I, Eden S, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Bates DW, Johnson DC, Labonville S, Gregory D, Kripalani S, PILL-CVD Study Group. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study. Circulation. Cardiovascular quality and outcomes. 2010 Mar 1; 3(2):212-9.
  384. Freiberg MS, McGinnis KA, Kraemer K, Samet JH, Conigliaro J, Curtis Ellison R, Bryant K, Kuller LH, Justice AC, VACS Project Team. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. Journal of acquired immune deficiency syndromes (1999). 2010 Feb 1; 53(2):247-53.
  385. Heisler M, Choi H, Rosen AB, Vijan S, Kabeto M, Langa KM, Piette JD. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Medical care. 2010 Feb 1; 48(2):87-94.
  386. Hays LM, Pressler SJ, Damush TM, Rawl SM, Clark DO. Exercise adoption among older, low-income women at risk for cardiovascular disease. Public health nursing (Boston, Mass.). 2010 Jan 1; 27(1):79-88.
  387. Virani S. Cardiovascular disease risk assessment and diagnosis in HIV infection. Paper presented at: American Heart Association Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living with HIV/AIDS Conference; 2009 Nov 5; Los Angeles, CA.
  388. Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W, Veterans Affairs Diabetes Trial. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes. 2009 Nov 1; 58(11):2642-8.
  389. Smith-Spangler C, Juusola J, Enns E, Owens DK, Garber AM. Desalination of the American diet: Population strategies to decrease sodium intake and the burden of cardiovascular disease. Poster session presented at: Society for Medical Decision Making Annual Meeting; 2009 Oct 19; Hollywood, CA.
  390. Banerjea R, Findley P, Sambamoorthi U, Bean-Mayberry B. Organization of Primary and Mental Health Care and Diagnosed Depression among Women Veterans with or at Risk for Cardiovascular Diseases. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 27; Chicago, IL.
  391. Paudel ML, Taylor BC, Ancoli-Israel S, Stone K, Tranah G, Redlines S, Barrett-Connor E, Stefanick M, Ensrud KE. Incident Cardiovascular Disease And Rest/Activity Rhythm Disturbances In Older Men: MrOS Sleep. Presented at: Associated Professional Sleep Societies, LLC Annual Meeting; 2009 Jun 7; Seattle, WA.
  392. Nanchen D, Rodondi N, Cornuz J, Hillier T, Ensrud KE, Cauley JA, Bauer DC. Mortality associated with diabetes and history of cardiovascular disease in older women. Paper presented at: Society of General Internal Medicine Annual Meeting; 2009 May 14; Miami Beach, FL.
  393. Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009 May 1; 204(1):298-303.
  394. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2009 Mar 17; 150(6):396-404.
  395. Akylbekova E, Dubbert PM, Wyatt S, Mosley T, Sims M, Taylor H, Payne T. Cardiovascular Disease and Depression in African Americans of the Jackson Heart Study. Paper presented at: American Heart Association Nutrition, Physical Activity and Metabolism / Cardiovascular Disease Epidemiology and Prevention Annual Scientific Sessions; 2009 Mar 11; Palm Harbor, FL.
  396. Funkhouser E, Christiansen CL, Palnati M, Lafrance JP, Pogach LM, Miller DR. Evaluating Drug Safety in VA: Cardiovascular Disease Risks with Rosiglitazone or Pioglitazone Use. Presented at: VA HSR&D National Meeting; 2009 Feb 14; Baltimore, MD.
  397. Kilbourne AM, Morden N, Austin K, Ilgen MA, Welsh D, McCarthy JF. Excess Cardiovascular Disease-Related Mortality in Veterans with Serious Mental Illness: Are Behavioral or Treatment Factors to Blame? Poster session presented at: VA HSR&D National Meeting; 2009 Feb 13; Baltimore, MD.
  398. Kilbourne AM, Welsh D, McCarthy JF, Post EP, Blow FC. Quality of care for cardiovascular disease-related conditions in patients with and without mental disorders. Journal of general internal medicine. 2008 Oct 1; 23(10):1628-33.
  399. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassaloti J, Whaley-Connell AT, Brenner RM, Bakris GL, KEEP Investigators. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. American heart journal. 2008 Aug 1; 156(2):277-83.
  400. Melloni, Wang, Peiper, Berger, Dolor, Mark, Newby. Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention. Journal of the American College of Cardiology. 2008 Jul 1; 51:A249-A250.
  401. Shlipak MG. Kidney Function and Cardiovascular Disease Outcomes in the Elderly. Paper presented at: American Society of Nephrology / Association of Specialty Professors on Chronic Kidney Disease in the Elderly Annual Workshop; 2008 May 9; Washington, DC.
  402. McCloskey E, Taylor BC, Kiel D, Ensrud K, Wilson K, Schousboe JT. Abdominal aortic calcification (AAC) on vertebral fracture assessment (VFA) images predicts incident myocardial infarction (MI) and stroke independent of clinical cardiovascular disease risk factors. Presented at: European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Annual Congress; 2008 Apr 9; Istanbul, Turkey.
  403. Bush RL, Kallen MA, Liles DR, Bates JT, Petersen LA. Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease. The Journal of surgical research. 2008 Apr 1; 145(2):313-9.
  404. Kilbourne AM, Welsh, McCarthy JF, Post EP, Blow FC. Cardiovascular Disease-related Conditions in Veterans with and without Mental Disorders. Paper presented at: VA HSR&D National Meeting; 2008 Feb 15; Baltimore, MD.
  405. Kilbourne, Greenwald, McCarthy, Welsh. Quality of Care for Cardiovascular Disease-related Conditions in Veterans with Mental Disorders. Presented at: VA HSR&D National Meeting; 2008 Feb 13; Baltimore, MD.
  406. Zeber JE, Parchman ML, Pugh JA. Cardiovascular disease in type-2 diabetes: using the UKPDS methodology to determine attributable risk variance across 20 community clinics. Poster session presented at: VA HSR&D National Meeting; 2008 Feb 13; Baltimore, MD.
  407. Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG, Health ABC study. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. American heart journal. 2008 Jan 1; 155(1):62-8.
  408. Mountford WK, Lackland DT, Soule JB, Hunt KJ, Lipsitz SR, Colwell JA. Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethnicity & disease. 2008 Jan 1; 18(2):131-5.
  409. Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. The American journal of medicine. 2008 Jan 1; 121(1):50-7.
  410. Schousboe JT, Taylor BC, Kiel DP, Ensrud KE, McCloskey EV. Abdominal aortic calcification (AAC) on vertebral fracture assessment (VFA) images predicts incident myocardial infarction and stroke independent of clinical cardiovascular disease risk factors. Presented at: American Society for Bone and Mineral Research Annual Meeting; 2007 Sep 16; Honolulu, HI.
  411. Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics. 2007 Sep 1; 48(5):412-7.
  412. Kilbourne AM, Post EP, Bauer MS, Zeber JE, Copeland LA, Good CB, Pincus HA. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. Journal of affective disorders. 2007 Sep 1; 102(1-3):145-51.
  413. Koya DL, Egede LE. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. Journal of general internal medicine. 2007 Jun 1; 22(6):841-6.
  414. Bird CE, Fremont AM, Bierman AS, Wickstrom S, Shah M, Rector T, Horstman T, Escarce JJ. Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans? Women's health issues : official publication of the Jacobs Institute of Women's Health. 2007 May 1; 17(3):131-8.
  415. Mosca L, Ganiats TG, Banka CL, Benjamin EJ, Bushnell C, Stone NJ, Gomes AS, Berra K, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Ouyang P, Scott R, Petitti D, Oparil S, Redberg RF, Dolor RJ, Sherif K, Pinn VW, Oz MC, Steinhorn RH, Wenger NK, Taubert KA, Sopko G, Urbina E, Smith SC, , Todd BA. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Journal of the American College of Cardiology. 2007 Mar 20; 49(11):1230-50.
  416. Mosca L, Ganiats TG, Banka CL, Benjamin EJ, Bushnell C, Stone NJ, Gomes AS, Berra K, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Ouyang P, Scott R, Petitti D, Oparil S, Redberg RF, Dolor RJ, Sherif K, Pinn VW, Oz MC, Steinhorn RH, Wenger NK, Taubert KA, Sopko G, Urbina E, Smith SC, , Todd BA. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007 Mar 20; 115(11):1481-501.
  417. Lynch EB, Liu K, Kiefe CI, Greenland P. Cardiovascular disease risk factor knowledge in young adults and 10-year change in risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. American journal of epidemiology. 2006 Dec 15; 164(12):1171-9.
  418. Robins SJ, Bloomfield HE. Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials. Current Opinion in Lipidology. 2006 Aug 1; 17(4):431-9.
  419. Piette JD, Lange I, Issel M, Campos S, Bustamante C, Sapag J, Poblete F, Tugwell P, O'Connor AM. Use of telephone care in a cardiovascular disease management programme for type 2 diabetes patients in Santiago, Chile. Chronic Illness. 2006 Jun 1; 2(2):87-96.
  420. Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC health services research. 2006 May 23; 6:58.
  421. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Archives of internal medicine. 2006 May 22; 166(10):1134-42.
  422. Koya D, Egede LE. Association between Cardiovascular Disease Risk Factors and Length of Residence among US Immigrants. Paper presented at: Society of General Internal Medicine Annual Meeting; 2006 May 1; Los Angeles, CA.
  423. Koya D, Egede LE. Racial/Ethnic Differences in Patterns of Cardiovascular Disease Risk Factors among US Immigrants. Paper presented at: Society of General Internal Medicine Annual Meeting; 2006 May 1; Los Angeles, CA.
  424. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. Journal of the American College of Cardiology. 2006 Jan 17; 47(2):473-84.
  425. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA. AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation. 2006 Jan 17; 113(2):316-27.
  426. Hong T, Bosworth HB, Dudley T, Oddone EZ. Perceived and actual risk of cardiovascular disease among hypertensive patients. The Gerontologist. 2005 Oct 1; 45(Sp. Iss. 2):666-667.
  427. Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, Kiefe CI, Powe NR, Rumsfeld JS, Spertus JA, Weintraub WS. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation. 2005 Jun 14; 111(23):3158-66.
  428. Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Progress in Cardiovascular Diseases. 2005 Mar 1; 45(6):429-41.
  429. Kim C, Eby E, Piette JD. Is education associated with mortality for breast cancer and cardiovascular disease among black and white women? Gender medicine. 2005 Mar 1; 2(1):13-8.
  430. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005 Jan 25; 111(3):250-3.
  431. Johnson ML, Pietz K, Battleman DS, Beyth RJ. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. The American journal of managed care. 2004 Dec 1; 10(12):926-32.
  432. Richardson CR, Kriska AM, Lantz PM, Hayward RA. Physical activity and mortality across cardiovascular disease risk groups. Medicine and science in sports and exercise. 2004 Nov 1; 36(11):1923-9.
  433. Kirkman S, McCarren M, Abraira C, Duckworth W. VADT Study Group: Cardiovascular disease correlates with traditional risk factors but not with glycemic control in established type 2 diabetes. Paper presented at: American Diabetes Association Annual Scientific Session; 2004 Jun 1; Orlando, FL.
  434. Yancy WS. Implications of low-carbohydrate diets for cardiovascular disease. Paper presented at: Kingsbrook Jewish Medical Center on Nutritional and Metabolic Aspects of Low Carbohydrate Diets Annual Conference; 2004 Jun 1; New York, NY.
  435. Heidenreich PA. Understanding and modifying physician behavior for prevention and management of cardiovascular disease. Journal of general internal medicine. 2003 Dec 1; 18(12):1060-1.
  436. Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular disease: what is the best approach? American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 2003 Oct 1; 3(5):339-49.
  437. Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA : the journal of the American Medical Association. 2003 Apr 2; 289(13):1659-66.
  438. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney international. 2002 Sep 1; 62(3):997-1004.
  439. Woodard L, Hernandez MT, Petersen LA. Racial Differences in Attitudes Regarding Cardiovascular Disease Prevention and Treatment: A Qualitative Study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
  440. Mozaffarian D, Kumanyika S, Lemaitre R, Olson J. Consumption of cereal fiber, fruit fiber and vegetable fiber and the risk of incident cardiovascular disease in older adults: the Cardiovascular Health Study. Paper presented at: American Heart Association Annual Scientific Sessions; 2002 Apr 12; San Diego, CA.
  441. Richardson CR, Hayward R, Lantz PM. The Benefits of Increasing Physical Activity in Low Income and High Cardiovascular Disease Risk Groups. Paper presented at: Cooper Institute Aerobics Research Annual Scientific Meeting; 2001 Oct 6; Dallas, TX.
  442. Natarajan S, Clyburn EB, Brown RT. Indigent Patient's Readiness to Change Health Behavior to Control Cardiovascular Disease Risk Factors. Paper presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2001 Aug 21; Seattle, WA.
  443. Douglas M. Nursing's Role in the Prevention of Cardiovascular Disease. Paper presented at: Mexican Society of Cardiology Annual Meeting; 2001 Mar 3; Mexico City, Mexico.
  444. Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. Diabetes Care. 2001 Jan 1; 24(1):39-44.
  445. Natarajan S, Mainous AG, Bradford WD, Kleckley T, Silverstein MD. Independent Effects of Cardiovascular Disease and Diabetes on Acute Health Care Utilization and Health Status. [Abstract]. Journal of general internal medicine. 2000 Sep 1; 15(11):87.
  446. Krumholz H, Brass L, Every N, Ashton C. Measuring and improving quality of care - A report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of healthcare quality in cardiovascular disease and stroke. [Abstract]. Stroke; A Journal of Cerebral Circulation. 2000 Jan 1; 31(4):1002-1012.
  447. Krumholz H, Brass L, Every N, Ashton C. Measuring and improving quality of care - A report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in cardiovascular disease and stroke. Circulation. 2000 Jan 1; 101(12):1483-1493.
  448. Siegel D. The gap between knowledge and practice in the treatment and prevention of cardiovascular disease. Preventive Cardiology. 2000 Jan 1; 3(4):167-171.
  449. Psaty BM, Weiss NS, Furberg CD, Koepsell TD, Siscovick DS, Rosendaal FR, Smith NL, Heckbert SR, Kaplan RC, Lin D, Fleming TR, Wagner EH. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA : the journal of the American Medical Association. 1999 Aug 25; 282(8):786-90.
  450. Adler A, Stratton I, Holman RR, Turner RC, UKPDS Study. Ethnicity and cardiovascular disease: The incidence of myocardial infarction in whites, South Asians, and Afro-Caribbean Patients with type II diabetes. Diabetes Care. 1998 Sep 15; 21:1271-1277.
  451. Ferguson JA, Tierney WM, Westmoreland GR, Mamlin LA, Segar DS, Eckert GJ, Zhou XH, Martin DK, Weinberger M. Examination of racial differences in management of cardiovascular disease. Journal of the American College of Cardiology. 1997 Dec 1; 30(7):1707-13.
  452. Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Annals of internal medicine. 1996 Feb 15; 124(4):414-21.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.